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A Systematic Analysis Of The Concordance Between Chromatin Accessibility
And Gene Expression Changes
Abstract
A major goal in the field of transcriptional regulation is the mapping of changes in the binding of
transcription factors to the resultant changes in gene expression. Recently, methods for measuring
chromatin accessibility have enabled us to measure changes in accessibility across the genome, which
are thought to correspond to transcription factor binding events. In concert with RNA-sequencing, these
data in principle enable such mappings; however, few studies have looked at their concordance over short
duration treatments with specific perturbations. Here, we used tandem, bulk ATAC-seq and RNA-seq
measurements from MCF-7 breast carcinoma cells to systematically evaluate the concordance between
changes in accessibility and changes in expression in response to retinoic acid and TGF-β. We found two
classes of genes whose expression showed a significant change: those that showed some change in
accessibility of nearby chromatin, and those that showed virtually no change despite strong changes in
expression. The peaks associated with genes in the former group had a lower baseline accessibility prior
to exposure to signal. Analysis of paired chromatin accessibility and gene expression data from distinct
paths along the hematopoietic differentiation trajectory showed a much stronger correspondence,
suggesting that the multifactorial biological processes associated with differentiation may lead to
changes in chromatin accessibility that reflect rather than drive altered transcriptional status. Together,
these results show many gene expression changes can happen independent of changes in accessibility
of local chromatin in the context of a single-factor perturbation and suggest that some changes to
accessibility changes may occur after changes to expression, rather than before.Furthermore, we
establish the role of cell-intrinsic differences in clonal melanoma cell lines leading to a rare subpopulation
of cells that demonstrate invasive behavior both in vitro and in vivo. This population is molecularly
characterized by the high expression of SEMA3C, and knockout studies demonstrate that the formation
of the invasives subpopulation is negatively regulated by the transcription factor NKX2.2. Overall, these
results establish a role for non-genetic differences in important cancer attributes such as cellular
invasion.
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ABSTRACT
A SYSTEMATIC ANALYSIS OF THE CONCORDANCE BETWEEN CHROMATIN
ACCESSIBILITY AND GENE EXPRESSION CHANGES
Karun Kiani
Arjun Raj

A major goal in the field of transcriptional regulation is the mapping of changes in the
binding of transcription factors to the resultant changes in gene expression. Recently,
methods for measuring chromatin accessibility have enabled us to measure changes in
accessibility across the genome, which are thought to correspond to transcription factor
binding events. In concert with RNA-sequencing, these data in principle enable such
mappings; however, few studies have looked at their concordance over short duration
treatments with specific perturbations. Here, we used tandem, bulk ATAC-seq and RNAseq measurements from MCF-7 breast carcinoma cells to systematically evaluate the
concordance between changes in accessibility and changes in expression in response to
retinoic acid and TGF-β. We found two classes of genes whose expression showed a
significant change: those that showed some change in accessibility of nearby chromatin,
and those that showed virtually no change despite strong changes in expression. The
peaks associated with genes in the former group had a lower baseline accessibility prior
to exposure to signal. Analysis of paired chromatin accessibility and gene expression data
from distinct paths along the hematopoietic differentiation trajectory showed a much
stronger correspondence, suggesting that the multifactorial biological processes
associated with differentiation may lead to changes in chromatin accessibility that reflect
rather than drive altered transcriptional status. Together, these results show many gene
x

expression changes can happen independent of changes in accessibility of local
chromatin in the context of a single-factor perturbation and suggest that some changes
to accessibility changes may occur after changes to expression, rather than before.
Furthermore, we establish the role of cell-intrinsic differences in clonal melanoma
cell lines leading to a rare subpopulation of cells that demonstrate invasive behavior both
in vitro and in vivo. This population is molecularly characterized by the high expression
of SEMA3C, and knockout studies demonstrate that the formation of the invasives
subpopulation is negatively regulated by the transcription factor NKX2.2. Overall, these
results establish a role for non-genetic differences in important cancer attributes such as
cellular invasion.
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CHAPTER 1: INTRODUCTION

I have always been inspired by the natural world. For example, Agave americana is a
flowering plant referred to more colloquially as the century plant that is native to the
semi-arid to arid climates of Northern Mexico and the American southwest. The century
plant, despite its moniker, lives only for about 10-30 years and has an interesting
strategy for reproduction: at the end of its life cycle, it sprouts a flowering stalk that can
stand up to 8 m tall to spread seeds and then soon thereafter dies. Every time I notice a
century plant in bloom I cannot help but wonder: how is it that one year the plant may
continue business as usual, while eventually, when the conditions are opportune, the
plant activates a complex genetic program to massively rewire its metabolism and
reroute all of its energy into growing and maintaining the flowering stalk as long as
possible (“Agave Americana (century Plant)” n.d.)?
To borrow concepts from control theory, I have been fascinated by how
dynamical biological systems are constantly able to maintain or achieve new states of
stability through the interaction of controllers, systems, and sensors (Strogatz et al. 1994;
Åström and Murray 2010). Specifically, in examples like the above, sprouting in the
century plant or other biological processes ranging from glucose homeostasis to
transdifferentiation to development, sensors constantly probe the environment and
activate or suppress complex gene regulatory programs in response to what may or may
not be going on.
The advent of recent technological advances in sequencing methods as well as
computational approaches to analyze these data have allowed for the quantification of
genetic, epigenetic, and transcriptional states of populations of cells as well as individual
1

cells at an unprecedented level. This abundance of data provides an opportunity to use
the principles of systems biology to begin to understand the interplay through which
transcriptional regulation is achieved.
The transcription of genes represents an output that results from the interplay of
nucleotide sequence, transcription factor binding, chromatin accessibility, and DNA
methylation, among a host of other factors. Throughout this dissertation my hope was to
pop the metaphorical hood of transcriptional regulation in dynamical biological systems
and begin to better understand and contribute to the conversation by examining the
relationship between different modalities of sequencing data (Chapter 2), and better
understanding the heterogeneity of phenotypes relevant to the natural history of disease
(Chapter 3).
1.1 Transcription factors and control of gene expression
A complex interplay of cis-regulatory elements such as promoters, enhancers, silencers,
and insulators, as well as transcription factors, control the level of gene expression,
which is important for development, establishing cell identity, and coordinating
transcriptional responses to a variety of stimuli. Genome-wide studies have estimated
200-300 transcription factors that bind directly to core promoter elements while an
additional approximately 1400 transcription factors that bind to a specific DNA
sequence and thus regulate only a specific subset of genes.
The importance of proper transcription factor control of gene expression is
underscored by the large corpus of evidence demonstrating the association of
transcription factor dysfunction with a wide array of human diseases ranging from
cancer to development disorders (Jimenez-Sanchez, Childs, and Valle 2001).

2

1.1.1 Structure and syntax of transcription factor activity
Transcription factors typically recognize degenerate DNA sequences that are 6-12 base
pairs in length. This straightforward sequence specificity suggests that additional, more
complex, rules are involved in controlling transcriptional output. One such level of
control is requiring combinatorial input of transcription factor binding. Transcription
factors often bind to enhancer regions that contain focused clusters of transcription
factor binding sites such that combinatorial binding can result in precise and distinct
patterns (Spitz and Furlong 2012). For example, in the fruit fly D. melanogaster, the
pMAD, the phosphorylated form of the transcription factor MAD, provides part of the
ability for cells to adopt a particular fate during development. It is the combinatorial
binding with cell-type specific transcription factors that confers cell-fate specification,
such as Tinman (Xu et al. 1998; H.-H. Lee and Frasch 2005) in the dorsal mesoderm or
Scalloped (Guss et al. 2001) for the wing imaginal disc.
Another method of control of transcription factor activity comes from not only the
timing of transcription factor expression, but also the timing of its DNA-binding activity
as demonstrated for mammalian myoblast differentiation with MYOD1 where some
enhancers are continuously bound while others are bound at only early or late stages in
development (Cao et al. 2010).
Finally, cooperativity serves to modulate transcription factor activity. This occurs
with regards to both (1) indirect effects that do not affect affinity for the cognate motif
and (2) direct effects that alter motif affinity. In the former case, the activity of two
transcription factors binding at a given enhancer can in some cases lead to increased
occupancy for each transcription factor (Voss et al. 2011). This occurs through both
synergistic action between the two transcription factors and nucleosome repositioning,
3

termed ‘assisted loading,’ as well as local bending of DNA which assists binding. In the
latter case, binding to a protein cofactor can affect the affinity of the two factors for their
respective motifs (Spitz and Furlong 2012). More recent works have also demonstrated
an alternative mechanism where protein-protein interactions can altogether change a
transcription factor’s DNA sequence specificity. For example, homeodomain-containing
Hox proteins in D. melanogaster when interacting with extradenticle (EXD) proteins
can induce subtle changes to DNA-binding specificities (Slattery et al. 2011). Thus,
transcription factors use a variety of methods to interact with local chromatin in order to
facilitate changes in gene expression.
1.1.2 Measuring the binding of transcription factors to DNA
Technologies that make use of chromatin immunoprecipitation combined with
microarray (ChIP-chip) or high-throughput sequencing (ChIP-seq) have been
instrumental in determining transcription factor-DNA binding patterns genome-wide
and still serve as the “gold-standard” for measuring protein-DNA interactions. Briefly,
they crosslink DNA-protein interactions and employ the use of a specific antibody
targeting the transcription factor of interest to pull down and subsequently sequence
only the chromatin sequences that are bound to the transcription factor. Similarly,
transcription factor-DNA interactions can be mapped globally using DamID, which uses
a fusion of a DNA methyltransferase domain to the DNA-binding protein of interest to
identify regions with adenine methylation. Other chromatin accessibility measuring
methods (mentioned later in this introduction) can also indirectly infer the activity of
transcription factors by looking for their “footprints” at sites of accessible chromatin.
One can categorize the binding sites from these methods based on features such as
nearest gene, the relative frequency of regions relative to gene structure (e.g. promoter,
4

intron, exon, etc.), or the type of chromatin domain. These data can then be compared
between conditions, cell lines and cell types, or transcription factors to begin to
understand the underlying regulation and logic of transcription factor binding.
1.1.3 Integration of ChIP-seq data with genome-wide expression data from
RNA-seq
Combining whole-genome transcriptomic data from RNA-sequencing (RNA-seq) with
transcription factor binding profiles from ChIP-seq provides a valuable opportunity to
study the interplay between transcription factor binding and gene transcription with
implications for both normal physiology and disease pathogenesis (Feng et al. 2014).
While there exist many tools that can be used “out of the box” for the analysis of these
data independently (Angelini and Costa 2014), the integration of these data types is not
trivial and presents one of the greatest challenges in modern biology (Gomez-Cabrero et
al. 2014). Early approaches use a variety of frameworks including a log-linear regression
model (Ouyang, Zhou, and Wong 2009) or a support vector regression (Cheng, Yan, Yip,
et al. 2011; Cheng, Yan, Hwang, et al. 2011; Cheng et al. 2012; Dong et al. 2012; Cheng
and Gerstein 2012). Many of these approaches attempted at using transcription factor
binding or histone modification data to predict gene expression within a condition.
Using these data to correlate variations of features of epigenetic marks and gene
expression between two conditions adds another level of complexity, and usually these
methods only show predictive power when categorizing gene expression as a categorical
output variable (i.e. upregulated, downregulated, or unchanged expression) (Klein et al.
2014). However, an important caveat of these approaches is that ChIP-seq data for
transcription factor binding is mainly based on a given binding peak’s proximity to the
transcriptional start site, and many existing approaches rely on local interaction. Owing
5

to the paucity of data and extra analysis considerations of techniques that map longrange chromatin interactions such as HiChIP and Hi-C, their integration with
transcriptomic data has been relatively under-explored (Angelini and Costa 2014).
1.2 Chromatin accessibility and gene regulation
The core structural unit of DNA packaging is referred to as a nucleosome, which
consists of approximately 147 base pairs of DNA wrapped around a hetero-octamer of
positively charged histone molecules much like a garden hose is wrapped around a reel.
The nucleosome serves as the cornerstone for the multiple layers of topological
complexity that allows the almost 3 meters of DNA to be confined within the volume of
the nucleus of eukaryotic cells.
Nucleosomal DNA is not evenly distributed across the genome, and varies greatly
between cell types, and even within the same cell type depending on context. DNA bound
to histone molecules is referred to as relatively inaccessible while nucleosome-free DNA
is thought to be more accessible in that it can be bound by other DNA-interacting
macromolecules such as transcription factors, architectural proteins, or polymerases. It
is helpful to conceptualize DNA along a continuum of inaccessible to accessible because
it has widespread consequences for gene regulation. For example, nucleosome-depleted
regions are commonly thought to represent non-coding DNA regions that are involved in
the regulation of expression of nearby genes, termed cis-regulatory elements and include
enhancers and promoters. Cis-regulatory elements exert these effects by interacting with
transcriptional regulators such as transcription factors. Indeed, while the accessible
portion of the genome is only approximately 3% of the total genome, over 90% of
transcription factor binding sites are confined to this accessible compartment (Thurman
et al. 2012). Nucleosomes are dynamic in terms of their positioning along the genome,
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their assembly and disassembly, and the myriad of post transcriptional modifications.
Thus, the topology of chromatin within 3 dimensional space provides an important point
of regulation of transcription.
1.2.1 Measuring bulk chromatin accessibility
Methods for measuring chromatin accessibility are based on enzymes being able to
physically interact with accessible chromatin in order to fragment, tagment, or
chemically label (e.g., methylate) these accessible portions of DNA (Boyle et al. 2008;
Schones et al. 2008; Hesselberth et al. 2009; Kelly et al. 2012; Buenrostro et al. 2013;
Minnoye et al. 2021). Early experiments in the 1970s used the endonuclease
deoxyribonuclease I (DNase I) to show promoters and introns of expressed genes are
more sensitive than other regions to digestion by DNase I, indicating that the chromatin
is particularly accessible in these regions.
With the establishment of high-throughput sequencing technologies, these
enzymatic methods could be combined with sequencing to begin to resolve chromatin
accessibility genome-wide. For example, DNase I hypersensitive site sequencing (DNaseseq) was one of the first instantiations of this approach and still is the approach of choice
for transcription factor footprinting, which can identify the location of transcription
factor binding sites due to the protection of the local chromatin from the transcription
factor itself (Hesselberth et al. 2009).
Using a micrococcal nuclease (MNase) in a technique called MNase-seq leverages
the ability of MNase to both act as an endonuclease to cleave internucleosomal DNA and
an exonuclease to degrade DNA not protected by proteins. This ability makes MNase-seq
particularly useful for isolating DNA fragments spanning a single nucleosome (West et
al. 2014). Alternatively, nucleosome occupancy and methylome sequencing (NOMe-seq)
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chemically modifies rather than cleaves accessible DNA using a GpC methyltransferase
to create sites of ectopic methylation of CG dinucleotides (nb: the endogenous
methylation of DNA found in both the human and mouse genomes occurs at CG
dinucleotides) (Kelly et al. 2012). NOMe-seq does not rely on any enrichment-based
steps and therefore requires a greater read depth compared to other methods. However,
this necessity also proves to be an advantage because it creates a more quantitative
measurement of accessibility compared to other techniques (Kelly et al. 2012; Minnoye
et al. 2021).
However, the current genome-wide chromatin accessibility method du jour for
almost the last decade has been Assay for Transposase-Accessible Chromatin and
sequencing, or ATAC-seq (Buenrostro et al. 2013) or one of its derivative variants
(Corces et al. 2016, 2017). A genetically engineered hyperactive transposase (Tn5) is
preloaded with Illumina adapters to simultaneously cleave and tag accessible chromatin
regions. These target DNA fragments are purified and amplified via PCR before being
sequenced using high-throughput technologies (Buenrostro et al. 2013). The major
advantages of ATAC-seq and its variants in that they require relatively low sample input
(500-50,000 cells versus millions needed for DNase-seq) and the protocol takes less
than a day to completely compared to the few days needed for DNase-seq or MNase-seq
(Buenrostro et al. 2013; Minnoye et al. 2021).
1.2.2 Chromatin accessibility at single-cell resolution
Advances in barcoding and microfluidic technologies have allowed the measurement of
chromatin accessibility at single-cell resolution. While these exist for many of the
methods mentioned for bulk profiling (e.g. scDNase-seq (Jin et al. 2015) or scMNase-seq
(Lai et al. 2018)), single-cell ATAC-seq (scATAC-seq) has become a popular approach
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due to its relative simplicity and reproducibility (Buenrostro et al. 2015; X. Chen et al.
2018; Cusanovich et al. 2015; Lareau et al. 2019; Satpathy et al. 2019).
Droplet based methods exist in multiple commercially available kits (e.g. Chromium
Next Gem Single Cell ATAC-seq or SureCell ATAC-seq) that when combined with
standard sequencing library reagents and proprietary robotic sample processing devices
allow for a relatively straightforward and reproducible approach to scATAC-seq.
Alternatively, plate-based methods (X. Chen et al. 2018; Mezger et al. 2018) require
single cells to be sequestered into individual wells of a plate but this approach limits
overall throughput of the assay. Given limitations and relative novelty of these
technologies, they will, for the most part, not be the focus of this dissertation but their
future use is discussed in more detail in Section 5.2 of chapter 5.
1.2.3 Integration of ATAC-seq and RNA-seq data
Many studies have examined the relationship between chromatin accessibility data and
gene expression data to some degree or another in an attempt to better understand
underlying regulation (González, Setty, and Leslie 2015; Ackermann et al. 2016; Ampuja
et al. 2017; Ramirez et al. 2017; de la Torre-Ubieta et al. 2018; Starks et al. 2019; Bunina
et al. 2020; Hota et al. 2022), but the analyses usually are the subject of at best one panel
of one figure. They often either focus on accessibility measurements at or near the
promoter only (Ampuja et al. 2017) or look at only at the relationship between chromatin
accessibility and gene expression (Starks et al. 2019) rather than the relationship
between their change over time or in response to some perturbation. Here, we sought to
rigorously and systematically characterize the concordance, or lack thereof, between
chromatin accessibility and gene expression data in response to single-factor
perturbations (Sanford et al. 2020; Kiani et al. 2022) to better understand the
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underlying logic of transcription in this context as well as limitation of the technologies
involved.
1.3 Cell-intrinsic differences and metastasis in melanoma
1.3.1 Disease and metastasis background
Owing to the high metastatic potential of cutaneous melanoma, it has been estimated by
the SEER database that the 5-year overall survival rate of stage IV metastatic melanoma
is approximately 30%, a value that has scarcely changed in the last twenty years (Song et
al. 2015). Metastasis refers to the result of a complex series of events where cancer cells
are able to leave the primary tumor and travel via lymphatic or hematological spread
before arriving at a different anatomical site and resuming proliferation. These events
are characterized by molecular changes that lead to distinct cellular phenotypes. In
particular, a cell must first become invasive to leave the primary tumor and migrate to
the site of metastasis and subsequently re-adopt a proliferative phenotype to establish
the metastatic nidus (Polyak and Weinberg 2009; Mittal 2018). Moreover, typically very
few cells from the original tumor will undergo the necessary steps to metastasize (Francí
et al. 2006; Mani et al. 2008).
1.3.2 Cell-autonomous differences and metastatic potential
While there exists evidence to support that the rare cells that do in fact leave the primary
tumor to metastasize do so due to external factors such as the tumor microenvironment
(Olmeda et al. 2017; Kaur et al. 2019), less work has characterized whether or not cellintrinsic factors prime certain cells for metastasis. More classically, the erstwhile factors
are considered to be mutations that drive an increased capacity for metastasis (Nataraj,
Marrocco, and Yarden 2021; Nguyen et al. 2022). However, more recently, the role of
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non-genetic changes in transcriptional regulation have also been implicated in driving
the phenotype switching to an invasive identity (Arozarena and Wellbrock 2019; Quinn
et al. 2021). Indeed, there is precedent demonstrating that non-genetic differences lead
to distinct behaviors in biology and cancer, specifically in the context of therapy
resistance (Symmons and Raj 2016; A. Raj and van Oudenaarden 2008; Emert et al.
2021; Goyal et al. 2021; E. A. Torre et al. 2021; Shaffer et al. 2017; Sharma et al. 2010;
Gupta et al. 2011). What is far less explored is how these non-genetic differences may
contribute to invasiveness in melanoma. Changes in expression of genes such as
ALDH1A1, KIT, and HSP90AB1 have been implicated in distinguishing metastatic
melanomas from their primary tumor counterparts (Metri et al. 2017; Turner, Ware, and
Bosenberg 2018).
1.4 Summary
Through two distinct, but related themes, in this dissertation I seek to better gene
expression regulation both through the context genome-wide omics methods to
developing new technologies to interrogate the role and consequences of non-genetic
heterogeneity to using established bioinformatic methods to better understand rare
invasive behavior in melanoma. As a whole, these themes move the field forward by
creating a framework for systematically examining the interplay of genome-wide
chromatin accessibility and gene expression data, allowing the combination of single-cell
transcriptomics with lineage information, and establishing a basis for a novel role of
NKX2.2 in melanoma metastatic potential.

11

CHAPTER 2: CHANGES IN CHROMATIN ACCESSIBILITY ARE NOT
CONCORDANT WITH TRANSCRIPTIONAL CHANGES FOR SINGLEFACTOR PERTURBATIONS

2.1 Introduction
2.1.1 Transcription factor activity and changes in gene expression
Transcription factors regulate gene expression by binding to specific DNA sequences,
facilitating transcription through the recruitment and activation of the transcriptional
machinery. Deciphering the combinatorial logic underlying which transcription factors
bind to what portions of DNA and in what contexts is a central challenge in creating a
complete model of transcriptional regulation. Sequencing-based methods have enabled
the measurement of transcript levels for all genes as well as the putative binding profiles
of transcription factors across the genome. However, the precise mapping between
changes in these putative binding profiles and the changes in transcriptional activity
remain the subject of debate.
2.1.2 Measuring transcription factor activity
A key component of decoding the relationship between transcription factor activity and
the resultant changes in transcription is the measurement of transcription factor binding
to DNA. Recently, the combination of biochemical binding assays with sequencing-based
readouts has led to a cornucopia of methods for making such measurements. One
workhorse method is chromatin immunoprecipitation sequencing (ChIP-seq), which
characterizes the binding of transcription factors and other DNA-protein interactions
genome-wide (Barski et al. 2007; Robertson et al. 2007; Ma and Zhang 2020) by using
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immunoprecipitation of proteins that bind to chromatin and subsequently sequencing
the coprecipitated DNA. However, ChIP-seq is limited in that each experiment can only
interrogate the binding profile of one transcription factor at a time.
An alternative approach that circumvents that issue is the measurement of
changes in accessibility of DNA to infer changes in the binding of all transcription factors
at once. Accessible regions of DNA (i.e. those regions depleted of nucleosomes) represent
only 3% of the genome, but often participate in the regulation of gene expression
(Weintraub and Groudine 1976; C. Wu, Wong, and Elgin 1979; C.-K. Lee et al. 2004;
Thurman et al. 2012). These regions can be detected genome-wide by combining the
enzymatic activity of nucleases with high-throughput sequencing using techniques such
as DNase I hypersensitive site sequencing (DNase-seq) (Boyle et al. 2008) and assay for
transposase accessible chromatin with sequencing (ATAC-seq) (Buenrostro et al. 2013).
The interpretation of these accessibility methods leans heavily on the assumption that
changes in regulatory factor binding are reflected in changes in chromatin accessibility.
Certainly, there are many examples in which the correspondence between changes in
accessibility strongly correspond to changes in transcriptional output. For instance,
summation of ChIP-seq signal for 42 transcription factors mapped by encode in K562
chronic myelogenous leukemia cells paralleled the signal from accessible sites revealed
by DNase-seq (Thurman et al. 2012). Moreover, computational methods to infer
transcription factor footprints from accessibility measurements have been shown to
recapitulate ChIP-seq binding well (Pique-Regi et al. 2011). Accessibility methods can
also be used to look for changes in accessibility across various perturbations and cell
types. Changes in accessibility generally seem to correspond to changes in transcription
in the sense that large changes in transcriptional output are reflected in broad changes in
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the accessibility of several loci in the surrounding chromatin (González, Setty, and Leslie
2015; de la Torre-Ubieta et al. 2018).
2.1.3 The relationship between chromatin accessibility and gene expression
changes
However, it is unclear how well these accessibility based methods capture the activity of
all transcription factors. It is possible that some transcription factors’ binding and
activity does not result in corresponding changes in accessibility and vice versa. Such a
lack of correspondence could manifest itself as a lack of correlation between changes in
accessibility and changes in transcription. Given the underlying assumption that a
change in transcription must be mediated by the change in some transcription factor
activity, then such a lack of correspondence would suggest that changes in the activity of
transcription factors could change expression without changing accessibility near its
binding site. While reports from the literature generally show a strong correspondence
(de la Torre-Ubieta et al. 2018; González, Setty, and Leslie 2015; Ampuja et al. 2017;
Starks et al. 2019), it is worth noting that the comparisons in such studies are often
across rather different cell types. In such cases, it is possible that the changes in
accessibility are not driven by regulation per se, but rather reflect the consequences of
sequential exposure to multiple regulatory factors that characterize the differentiation
process. Such accessibility changes could, in principle, signify the reinforcement of genes
that are already transcriptionally active genes, or could even just appear around actively
transcribed genes without any functional role. Disentangling such possibilities could be
revealed with the use of single-factor perturbations that more directly affect an
individual pathway; however, few such data are available.
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Here, we used tandem bulk RNA-seq and ATAC-seq data from MCF-7 breast
carcinoma cells exposed to multiple doses of retinoic acid or TGF-β to determine the
degree of concordance between changes in chromatin accessibility and changes in gene
expression. Furthermore, we evaluated concordance in another published data set of
hematopoietic differentiation to validate our approach based on well-defined and
specific perturbations. We demonstrate that while some differentially expressed genes
have a high concordance between gene expression and chromatin accessibility changes,
many other genes are differentially expressed without changes in their local chromatin
accessibility.
2.2 Results
2.2.1 Genome-wide expression and chromatin accessibility changes reflect
known biology of two perturbations
To measure the correspondence between changes in chromatin accessibility and changes
in gene expression, we used MCF-7 breast carcinoma cells due to their previously
described transcriptional responses to all-trans retinoic acid (Hua et al, 2009) (referred
to from here on as retinoic acid) and transforming growth factor beta (TGF-β) (Mahdi et
al, 2015). We used paired, bulk accessibility (ATAC-seq) and expression data (RNA-seq)
from these cells (Sanford et al, 2020) collected 72 hours after continuous exposure to
three different doses of each signal (Figure 2.1). We chose this timescale because
previous work with MCF-7 cells showed more transcriptional changes at 72 hours
compared to 24 hours after exposure to retinoic acid (Hua et al, 2009), and chromatin
accessibility changes may not be detectable until 24 hours after perturbation (Ramirez et
al, 2017). Differential gene expression and differential peak accessibility analysis showed
15

a dose-dependent response to both signals compared to ethanol control (Figure 2.1, bar
plots). The ethanol ‘vehicle’ controls comprise three different densities of cells, and the
transcriptomes of control conditions globally were similar regardless of cell density
(Figure 2.2). To confirm that global gene expression and chromatin accessibility
patterns were similar between signals and dosages, we performed principal component
analysis. For both RNA-seq and ATAC-seq data, all samples exposed to the same signal
or ethanol control clustered together, indicating that their gene expression and
chromatin accessibility were more similar to each other than to other conditions,
supporting the quality of these data.
To validate that changes in gene expression were consistent with the known
biology of these signaling pathways, we performed over-representation analysis on the
upregulated genes in response to high dose retinoic acid or TGF-β against curated gene
sets from the molecular signatures database (Liberzon et al, 2011, 2015). The top ten
gene sets based on false discovery rate (FDR)-adjusted p-values were processes
canonically associated with retinoic acid (morphogenesis, organ development, anteriorposterior patterning) and TGF-β (extracellular matrix, endopeptidase activity),
respectively (Figure 2.3). Gene set enrichment analysis (Subramanian et al, 2005)
showed that genes that were differentially expressed in response to high dose retinoic
acid were significantly enriched for genes associated with skeletal system
morphogenesis, and genes that were differentially expressed as a result of exposure to
high dose TGF-β were significantly enriched for genes associated with epithelial-tomesenchymal transition (Figure 2.4). Thus, the differentially expressed genes generally
reflected the known biology of the signals the cells were exposed to.
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We next wondered if the changes in chromatin accessibility in response to signal
were associated with the activity of specific transcription factors, in particular, those
associated with the biology of these signaling pathways. We used a modified version of
the chromVAR package along with its curated database of transcription factor motifs,
cisBP, to identify the transcription factors with the largest predicted change in activity
(Schep et al, 2017). We used the set of differential peaks to determine the set of the top
150 transcription factors with the greatest magnitude of change. These included the
binding motifs of transcription factors that are canonical effectors of retinoic acid (RARα, HOXA13) and TGF-β signaling (SMAD3, SMAD4, and SMAD9). For each of these
transcription factor motifs, we calculated a motif enrichment score for each condition
based on the bias-uncorrected deviation score from chromVAR. The motif enrichment
score represents the percentage change in ATAC-seq fragment counts in all peaks that
contain a given transcription factor’s motif (Figure 2.5). For example, the enrichment
score of 28% for SMAD3 in the TGF-β condition meant that peaks containing the
SMAD3 motif on average saw a 28% increase in fragment counts after exposure to TGFβ. We pooled together the low, medium, and high doses for each condition together in
order to decrease the variability of motif enrichment scores estimates. Thus, our data
recapitulated expected changes in accessibility, presumably due to the activity of
transcription factors well-known to be activated by the signals used. Thus, of the changes
in accessibility we did detect, they made sense based on a model of transcription factor
activity leading to changes in accessibility. However, it was still possible that the activity
of many transcription factors was not captured by changes in accessibility.
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2.2.2 The relationship between changes in chromatin accessibility and gene
expression varies on a gene by gene basis
We next wondered whether genes that were differentially expressed were more likely to
have differentially accessible peaks nearby, i.e., was there concordance between gene
expression and chromatin accessibility changes at the level of individual genes? To
characterize the extent of concordance between these data, we looked at the overlap
between genes that were differentially expressed in response to high dose signal and
genes with differentially accessible peaks nearby after exposure to signal (Figure 2.6).
We assigned each accessible peak to the nearest transcriptional start site (“nearest
approach”) and found that of the over 2000 genes upregulated in response to high dose
retinoic acid, more than half of them had at least one differential peak assigned to its
transcriptional start site (p-value < 2.2x10-16, Fisher’s exact test). Similarly, a third of
the genes whose expression was upregulated in response to TGF-β had differential peaks
assigned to them (p-value < 2.2x10-16, Fisher’s exact test). Thus, genes that are
differentially expressed are more likely than random chance to have a nearby peak that is
differentially accessible in response to retinoic acid or TGF-β.
While using this overlap-based approach showed correspondence between genes
that are differentially expressed and their nearby peaks in response to signal, aspects of
the nature of the concordance of these changes were not captured by this analysis. For
example, the overlap-based method counted all differentially accessible genes that had at
least one differentially accessible peak assigned to them as concordant, but did not take
into account the proportion or degree to which those nearby peaks change. Moreover, we
did not take into account the relationship between directionality of changes in gene
expression and chromatin accessibility. The underlying assumption at the basis of this
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relationship is that when peaks become more accessible that the nearby gene increases
its expression, and the overlap-based approach does not take this correspondence of the
direction of change into account. To better characterize these facets of concordance, we
first individually examined the changes in chromatin accessibility nearby two genes
whose expression were upregulated in response to retinoic acid.
HOXA1 and SLC5A5 induction are associated with exposure to retinoic acid (Glover et
al, 2006; Schmutzler et al, 1997; Kogai et al, 2000), and both genes showed a dosedependent increase in expression in response to retinoic acid (Figures 2.7A, B). After
optimizing parameters for calling peaks and determining differentially accessible peaks
(Figure 2.8), we found that while a large number of peaks are differentially accessible
near the HOXA1 locus (Figure 2.7A, track view middle, black traces in accessibility
plot, right), very few peaks are differentially accessible near the SLC5A5 locus (Figure
2.7B, track view middle, accessibility plot, right). Therefore, genes with high expression
change in response to signal can show a large degree of accessibility changes or show
very little accessibility changes, suggesting that changes in transcription factor activity
may or may not be reflected in changes in accessibility.
2.2.3 Chromatin accessibility changes are less concordant with large
changes in gene expression in signaling compared to hematopoietic
differentiation
Next, we evaluated the concordance between accessibility and gene expression genomewide while also factoring in the directionality of changes and the relative proportion of
peaks that are changing on a gene-by-gene basis. As a point of comparison, we used
previously published gene expression and chromatin accessibility data from
hematopoietic differentiation (González et al, 2015) that demonstrated that large
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changes in gene expression were typically associated with gains or losses (depending on
the direction of expression change) of cell type-specific enhancers when comparing the
expression and accessibility of hematopoietic stem and progenitor cells (HSPCs) to
monocytes.
Before using this data set as a comparison to ours for measuring concordance
between chromatin accessibility and gene expression changes, we verified that the
hematopoietic differentiation data was similar to our own by a variety of metrics. First,
we wanted to compare whether the number of differentially expressed genes and
differentially accessible peaks between HSPCs and monocytes in the hematopoietic
differentiation data was similar to the numbers from MCF-7 cells exposed to retinoic
acid or TGF-β. We found that both HSPC and monocyte populations had greater than
2000 genes that were specifically expressed in their respective cell types compared to the
approximately 2000 and 1500 genes differentially expressed in MCF-7 cells in response
to high dose retinoic acid and TGF-β, respectively (Figure 2.1). Moreover, HSPC and
monocyte populations had more than 6000 differentially accessible peaks (Supplemental
Figure 3A) compared to the approximately 15000 and 6000 differentially accessible
peaks in MCF-7 cells in response to high dose retinoic acid and TGF-β, respectively
(Figure 1A).
Next, we annotated the location of peaks based on where in the genome they were
located relative to gene bodies and quantified what proportion of peaks fell into
annotation categories such as promoter, intergenic, exonic, intronic, etc. ATAC-seq
peaks from MCF-7 cells had a larger proportion of peaks at gene promoters (within 3
kilobases upstream or downstream of the transcription start site) whereas a greater
proportion of the DNase I hypersensitive sites in the HSPC and monocyte populations
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were from distal intergenic regions compared to promoters (Figures 2.9A, B). This
finding could be the result of inherent differences in the assays or could reflect biological
differences. Moreover, the MCF-7 data had a greater proportion of peaks located at gene
promoters, which could in principle bias our results toward having a larger degree of
concordance because accessibility changes at promoters were more strongly correlated
with gene expression changes than distal accessible. Despite this bias, our data
demonstrate less concordance.
Given the different assays used to determine genome-wide chromatin
accessibility, we realigned the DNase-seq data to the hg38 reference and examined the
peaks at a ‘housekeeping gene’ (GAPDH), hematopoietic differentiation-specific genes
(CD34, CD14) and retinoic acid and TGF-β-related genes (DHRS3, SERPINA11) to spotcheck that the accessibility data were similar. Indeed, there were similar accessibility
profiles for GAPDH, and appropriate differences in accessibility given the cell type of
signal for the other sites, indicating the accessibility data were comparable (Figure
2.10). Moreover, to look at similarities in accessibility genome-wide, we calculated the
intersection of the consensus peak sets from hematopoietic differentiation and MCF-7
signal response data sets. We observed that approximately 55% of peaks from
hematopoietic differentiation data (DNase-seq) overlapped with peaks from the MCF-7
signal response data set (ATAC-seq). These results show that the datasets do not have
systematic qualitative differences in either expression or accessibility, enabling us to
compare the degree of concordance across these two systems.
In the original analysis of hematopoietic differentiation, the authors found that
regulatory complexity (defined as the number of accessible regions closest to a gene’s
transcriptional unit) was an important discriminating factor for whether changes in
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accessibility corresponded to changes in expression, with areas of high complexity
showing more correspondence than those of low complexity. Hence, we similarly
grouped genes from our MCF-7 dataset into high and low complexity for our
comparisons. We categorized genes with more than 7 peaks assigned to them using the
‘nearest approach’ as ‘high complexity’, while genes with 7 or fewer peaks were
categorized as having ‘low complexity’ (Figure 2.11). The cutoff for loci complexity was
calculated by taking a tertile based approach (González et al, 2015) and calling any
number of peaks above the highest tertile cutoff as high and any peak below that as low
complexity (Figure 2.12). Because high complexity genes on average had higher levels
of expression in the hematopoietic differentiation data, we sought to determine if there
was any difference in expression between high and low complexity genes in our MCF-7
data. The median expression of high complexity loci was similarly higher than low
complexity loci in response to both exposure to high dose retinoic acid (23.30 versus
13.27 TPM) and high dose TGF-β (24.06 versus 13.05 TPM) (Figure 2.13A, p-value <
2.2x10-16 for both, Kolmogorov-Smirnov test) demonstrating that high complexity genes
are more highly expressed as in the hematopoietic differentiation data. Despite this
difference in expression, the distributions of peak widths for peaks of high and low
complexity genes were similar (Figure 2.13B).
We began our analysis by focusing on the high complexity genes. To determine
the concordance between gene expression changes and chromatin accessibility changes,
we used the ‘nearest approach’ to assign peaks to genes. For each gene we compared the
log2 of the fold change in expression between conditions versus the proportion of peaks
that were differentially accessible in the same direction (i.e., peaks that increase in
accessibility for genes that increase in expression after exposure to signal and vice versa).
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We observed that for hematopoietic differentiation, the 100 most highly expressed high
complexity genes in the HSPC and monocyte populations had a high proportion of peaks
which were differentially accessible in the concordant direction, reproducing the
conclusions of González et al. that large changes in expression were consistently
associated with concordant changes in chromatin accessibility (Figure 2.14A). Next, we
used this approach on our data to compare expression and accessibility changes between
ethanol vehicle control and high dose retinoic acid or TGF-β. For both signals, we
observed two distinct groups of genes within the top 100 most differentially expressed
genes. One group of genes (‘accessibility-concordant genes’) behaved similarly to those
in the hematopoietic differentiation data, demonstrating a concordance between
expression and accessibility changes (Figures 2.14B,C). However, the other group of
genes (‘accessibility-non-concordant genes’) had large expression changes with little to
no peaks nearby changing in accessibility, creating a skew in the distribution toward a
lower proportion of peaks being differentially accessible in a concordant manner
compared to the hematopoietic differentiation data (Figures 2.14A-C, density plots).
Adjusting the minimum peak coverage parameter changes the number of
differential peaks and the proportion of differential peaks that change in the
corresponding direction of expression. We wondered if a lower minimum coverage
threshold changed the qualitative result we noticed before and thus conducted the same
analysis using a lower minimum peak coverage threshold for determining differential
peaks (see methods). We observed that a similar pattern occurred in high complexity
genes with this set of parameters (Figures 2.15A, B).
González and colleagues showed that for some low complexity genes, large
changes in expression were not accompanied with concordant changes in accessibility
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(González et al, 2015). We similarly wanted to confirm whether this decreased
correspondence was the case in our data in response to retinoic acid and TGF-β. Using
the same approach as before, we compared the log2 of the fold change in expression of
low complexity genes to the proportion of peaks with differential accessibility in the
concordant direction. The hematopoietic differentiation and signaling data for low
complexity all qualitatively had genes whose expression increased without concordant
changes in accessibility (Figures 2.16A-C). The distribution of the proportion peaks
that were differentially accessible in the concordant direction for the top 100 up and
downregulated genes was roughly uniform when comparing HSPCs to monocytes
(Figure 2.16). By comparison,the distribution was skewed toward more genes having a
lower proportion of peaks being differentially accessible in the concordant direction in
response to signals in MCF-7 cells, especially in the case of TGF-β (Figure 2.16, density
plots on right). Thus, while both the signaling in MCF-7 and hematopoietic data
demonstrated large gene expression changes without concordant changes in chromatin
accessibility with low complexity genes, a greater proportion of genes did so in the
signaling data.
2.2.4 Peaks nearby genes with high concordance have lower accessibility
prior to exposure to signal
We wondered what the differences were between genes that were differentially expressed
and had large accessibility changes versus those that were differentially expressed and
had low accessibility changes. First, for high dose retinoic acid and TGF-β, we split genes
into four groups based on whether they were differentially expressed and the proportion
of peaks assigned to them using the ‘nearest’ method that were differentially accessible
in the appropriate direction. These four groups were (1) genes with differentially
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upregulated expression and concordant accessibility changes (2) genes with differentially
upregulated expression non-concordant accessibility changes (3) genes with
differentially downregulated expression and a concordant accessibility changes, and (4)
genes with with differentially downregulated expression and non-concordant
accessibility changes (Figures 2.17A,B). We quantified the distribution of peak
complexity across these groups and observed that they were similar across all four gene
subgroups (Figures 2.18A,B).
We first asked whether the change in accessibility between these two gene groups was
due to differences in the preexisting accessibility of peaks for these genes. Indeed, we
found the baseline accessibility of peaks for genes with concordant increases in
expression and accessibility in ethanol vehicle conditions was lower than those of peaks
of genes that increase in expression without a commensurate change in chromatin
accessibility (Figure 2.18C). This relationship was also recapitulated for concordant
peaks that increase in expression and accessibility in response to high dose TGF-β
(Figure 2.18D). Similarly, when comparing genes that are differentially downregulated
in expression a similar pattern holds true in the opposite direction (Figures 2.17C,D,
Figures 2.18C,D). One explanation may be that genes whose nearby chromatin was
already accessible were permissive toward the action of the appropriate transcription
factors to modulate expression. An alternative explanation is that the ATAC-seq assay
itself had saturated in its ability to measure chromatin accessibility. In contrast, the
difference in accessibility decreased between genes with a low proportion of peaks that
were differentially accessible and genes with a high proportion of accessible peaks after
exposure to signal (Figures 2.18C,D). Thus, the difference in the proportion of
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accessible peaks nearby the two groups of genes was partially explained by the preexisting chromatin accessibility.
2.2.5 Multiple approaches to integrating chromatin accessibility and gene
expression changes show a low degree of concordance during signaling.
Finally, we measured to what degree the change in accessibility of chromatin nearby a
gene is reflected in the change in gene expression. Because linear distance is not always a
good predictor of what accessible regions interact with what genes, we used multiple
approaches to assign peaks to genes. First, we used the ‘nearest approach’ to create a
one-to-one mapping between accessible sites and genes by assigning them to the nearest
transcriptional start site (Nair et al, 2021; Li et al, 2012), again comparing our signaling
dataset to the hematopoietic differentiation dataset. Because many genes have multiple
peaks assigned to them, we used two methods for collapsing peak values per gene: either
the median accessibility of peaks across genes or the maximum (Figure 2.19A,
schematic). We observed a stronger correlation between accessibility and expression
changes in differentiation data (median approach Pearson’s r = 0.34, maximum
approach Pearson’s r = 0.26) than in MCF-7 in response to signal (retinoic acid: median
approach Pearson’s r = 0.27, maximum approach Pearson’s r = 0.10; TGF-β: median
approach Pearson’s r = 0.27, maximum approach Pearson’s r = 0.10; Figure 2.19A,
right side).
Next, we used a window-based approach where there was the possibility of a
many-to-one mapping of peaks to genes. We assigned all peaks within a 100 kilobase
window (Sanford et al, 2020) in order to maximize the number of differential peaks
assigned to a gene (Figures 2.20A,B). Similar to the ‘nearest’ approach, we collapsed
values using median accessibility change across all peaks assigned to a gene as well as
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maximum accessibility per gene (Figure 2.19B, schematic) We observed a similar effect
using this approach where there was a stronger correlation between change in
accessibility and change in expression between HSPC versus monocyte versus MCF-7
cells exposed to signal (Figure 2.19B). Of note, the correlation coefficients were similar
between both methods of assigning peaks.
We also wondered if the correlation between the extent of chromatin accessibility
changes and gene expression changes would be different at the two lower doses. We used
both the median and maximum peak value per gene while assigning peaks to genes using
the nearest and window approaches. We observed similarly weak correlation as high
dose signal using all methods at both low and medium doses (Figures 2.20C,D).
Consequently, the correlation between the magnitude of change in gene expression and
chromatin accessibility was modest across the range of doses of signals.
To see if peaks in specific genomic regions (promoters, parts of the gene body,
downstream and intergenic areas) had unique relationships between change in
chromatin accessibility and change in gene expression, we subsetted our correlation
analysis. We annotated peaks using ChiPseeker (Yu et al, 2015) to categorize them as
being at promoters, within the gene body (5’ UTR, 3’ UTR, intronic, and exonic
sequences), downstream of the gene end, or at intergenic sequences. We used peaks
assigned to genes using the ‘nearest’ approach and took the median change in
accessibility per gene. The strongest correlation between changes in accessibility and
gene expression across sets of comparisons was at promoter peaks (Figure 2.19C).
While promoter correlation is quantitatively stronger, the overall qualitative conclusion
remains the same. Thus, despite using a variety of approaches for both assigning peaks
to genes as well as collapsing the accessibility of all peaks for a given gene to a single
27

value, we failed to appreciate a strong relationship between changes in accessibility and
changes in gene expression.
Finally, we wondered if peaks that contained the motifs of transcription factors
that are associated with retinoic acid and TGF-β signaling only (as opposed to all peaks)
would show a stronger correlation between the changes in chromatin accessibility and
gene expression. We annotated peaks with a log-likelihood score of a given motif being
found in that peak and subsetted on those peaks with a nonzero log-likelihood score to
examine the correlation between changes in accessibility and gene expression. Using this
approach, we examined log-likelihood scores for motifs associated with retinoic acid
signaling (RARA-α, HOXA13, and FOXA1) and motifs associated with TGF-β (SMAD3,
SMAD4, and SMAD9). We observed that focusing on peaks annotated with peaks we
would a priori expect to be involved in modulating gene expression in response to signal
showed limited correlation between changes in chromatin accessibility and changes in
gene expression (Figure 2.21).
2.3 Discussion
Here, we integrated tandem, genome-wide chromatin accessibility and transcriptomic
data to characterize the extent of concordance between them in response to inductive
signals. We demonstrated that while certain genes have a high degree of concordance of
change between expression and accessibility changes, there is also a large group of
differentially expressed genes whose local chromatin remains unchanged. By
comparison, data from cell types along the hematopoietic differentiation trajectory had a
much higher degree of concordance between genes with large gene expression changes
and chromatin accessibility changes.
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What might explain the lack of concordant changes in chromatin accessibility?
One explanation could be that pre-existing chromatin accessibility dictates the de novo
binding of transcription factors, but that the binding of transcription factors to those
regions does not result in further changes to accessibility. Such effects have been
reported in the context of glucocorticoid signaling, in which the glucocorticoid receptor
almost exclusively binds to chromatin that is already accessible in response to
dexamethasone (John et al, 2011). Indeed, we demonstrated that genes that lacked
concordance between changes in chromatin accessibility and gene expression were more
likely to have nearby chromatin that was already accessible (Figures 3C,D). It is possible
that in MCF-7 cells, the transcriptional effects of RA and TGF-β do not lead to a
significant change in the activity of pioneer transcription factors, which are able to bind
directly to condensed or inaccessible chromatin to facilitate its opening (Zaret, 2020).
Also, implicit in our approach is the assumption that an increase in accessibility is
associated with an increase in expression, which is not necessarily the case if a genomic
locus becomes accessible to a repressive factor or a bound repressive factor is displaced
by a nucleosome.
We looked at MCF-7 cells exposed to retinoic acid and TGF-β because these two
signals induce a robust transcriptional response through distinct mechanisms. RAR-α
remains bound to DNA and interacts with transcriptional activators in response to
retinoic acid binding, while SMAD family members require TGF-β to bind to surface
receptors to translocate to the nucleus. Yet, despite these differences, we observed that
many genes changed expression independent of changes in chromatin accessibility for
both signals. It is, however, possible that signaling molecules that exert their effects
through very different types of transcription factors may have a different profile of
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concordance between changes in accessibility and gene expression. It is possible that
other types of factors in a different context (e.g., different cell line) may yield a stronger
correspondence.
Our data characterized molecular changes resulting from a single input (retinoic
acid or TGF-β) in a clonal cell line, whereas the majority of work reporting a stronger
concordance between simultaneous measurements of accessibility and transcription
compared entirely different cell types or cells undergoing a directed differentiation
protocol. What we have observed in the case of a single perturbation applied to cells that
are not thought to change type per se is increased or decreased transcription with less
concomitant nearby change in accessibility. How can one reconcile these observations?
One possibility is that if we were to leave the signal on for longer, or combine it over time
with the effects of several other signals, that we eventually would observe many further
changes in accessibility proximal to a gene, concordant with the aforementioned results
from comparisons between cell types. Whatever the source, these further changes in
accessibility do not seem to occur randomly, given that they largely reflect the direction
of change in transcription (increased accessibility for upregulation, decreased for
downregulation). It may be that these subsequent changes in accessibility do not
explicitly change transcription, but rather alter the underlying regulatory logic of the
gene; i.e., the removal of a signal may not lead to a decrease in the gene’s transcription,
or the gene’s transcription may be sensitized or desensitized to some other set of
transcription factors.
2.4 Contributions
This chapter contains direct quotes and figures from Kiani et al. published in 2022 in
BioRxiv [in revision, Molecular Systems Biology] (Kiani et al. 2022). We are greatly
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indebted to Professor Christina Leslie and Alvaro González for many insightful
discussions and for assistance in working with their datasets. We also thank the
members of the Raj lab for valuable feedback, especially Ally Coté and Lee Richman.
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Figure 2.1 Schematic of tandem RNA-seq and ATAC-seq data.
Cells were treated with either ethanol vehicle control (gray) or three different doses of
retinoic acid (shades of red) or TGF-β (shades of blue). After 72 hours of continuous
exposure, bulk RNA-seq and ATAC-seq were performed on samples. We show the
number of differentially expressed genes and differentially accessible peaks for each dose
of each condition compared to ethanol vehicle control.
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Figure 2.2 Global analysis of expression and chromatin accessibility changes
in response to varying signals in MCF-7 cells.
PCA of variance stabilizing transformed raw counts from gene expression and chromatin
accessibility data demonstrating the first two principal components.
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Figure 2.3 Validation that changes in gene expression reflect known biology
of perturbations.
Overrepresentation analysis of differentially upregulated genes in response to high dose
retinoic acid (red) or TGF-β (blue). Top ten gene sets for each signal by -log10 FDRadjusted p-value are shown.

Figure 2.4 Gene set enrichment analysis of expression data further
corroborates that expression changes reflect known biology of
perturbations.
Gene set enrichment analysis (GSEA) (Subramanian et al, 2005) of differentially
expressed genes in response to high dose retinoic acid against a gene set for skeletal
system morphogenesis. Genes whose expression were differentially expressed in
response to TGF-β were enriched for genes associated with epithelial-to-mesenchymal
transition. Green traces represent running enrichment scores across fold change ranked
gene lists.
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Figure 2.5 Validation that changes in chromatin accessibility reflect known
biology of perturbations.
Motif enrichment analysis of differentially accessible peaks for selected motifs of
transcription factors related signaling pathways of these signals. Y-axis shows percentage
change of ATAC-seq signal at motif containing peaks relative to ethanol vehicle control
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samples. For each condition, we pooled together replicates for all three doses. Error bars
represent bootstrapped confidence intervals.
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Figure 2.6 Overlap between changes in gene expression and changes in
chromatin accessibility in response to high dose retinoic acid or high dose
TGF-β.
Of the genes that were differentially expressed (right circle of Venn diagram) we looked
at the overlap (shaded) of how many of them also had at least one differentially
accessible peak (left circle). To disprove the null hypothesis that there is no association
between genes that are differentially expressed and genes that have differentially
accessible peaks assigned to them using the ‘nearest’ approach, we performed Fisher’s
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exact test to show the probability of these data or more extreme if the null hypothesis
was true for both signals was less than 2.2x10-16.
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Figure 2.7 Expression and accessibility change of HOXA1 and SLC5A5 in
response to increasing doses of retinoic acid.
(A) Left: Expression (TPM, triplicate average) in response to increasing dose of
retinoic acid (error bars represent SEM). Middle: track view of HOXA1 locus with
accessibility in fragments per million and peaks and differential peaks annotated.
Right: quantification of peak accessibility (normalized fragment counts, triplicate
average) within a 50 kilobase window of HOXA1 locus with peaks that are
differentially accessible between ethanol vehicle control and high dose retinoic
acid conditions marked with black lines.
(B) Left: Expression (TPM, triplicate average) in response to increasing dose of
retinoic acid (error bars represent SEM). Middle: track view of SLC5A5 locus
with accessibility in fragments per million and peaks and differential peaks
annotated. Right: quantification of peak accessibility (normalized fragment
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counts, triplicate average) within a 50 kilobase window of SLC5A5 locus with
peaks that are differentially accessible between ethanol vehicle control and high
dose retinoic acid conditions marked with black lines.
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Figure 2.8 Tuning peak calling parameters
Representative peak calls at the CYP26A1 using different peak merge parameters (colors)
and minimum normalized fragment count coverage (shades of the same color). Based on
these results we selected a merge distance of 50 base pairs and a minimum coverage of
30 normalized fragment counts.
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Figure 2.9 Comparison of accessibility data from hematopoietic
differentiation and MCF-7 cells in response to signal.
(A) Number of differentially expressed genes (left) specific to CD34+ hematopoietic
stem and progenitor cells (HSPCs, blue) and CD14+ monocytes (orange) from
data from González et al., 2015 and the number of differentially accessible peaks
(DNase-seq) between the two populations (right).
(B) Annotation of distribution of peak location in relation to gene transcriptional
units for consensus files for HSPCs and monocytes (left). Distribution of
accessible peak features for consensus peaks for MCF-7 cells in ethanol, high dose
retinoic acid, and high dose TGF-β.
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Figure 2.10 Comparison of peak calls at multiple loci across both
hematopoietic differentiation and MCF-7 genome-wide accessibility data
sets.
Consensus peak calls for MCF-7 signal samples (ATAC-seq) and hematopoietic
differentiation samples (DNase-seq) at a ‘housekeeping’ gene GAPDH, hematopoietic
cell-specific marker loci CD34 and CD14, a retinoic acid responsive site, DHRS3, and a
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TGF-β responsive site SERPINA11. Values are fragments per million for ATAC-seq
samples and counts per million for DNase-seq samples.

Figure 2.11 Schematic demonstrating classification of genes into “high”
versus “low” complexity genes based on the number peaks assigned to a
gene using the ‘nearest’ approach.
High complexity genes (light green) are characterized by greater than 7 peaks assigned to
a given gene by the ‘nearest’ approach while low complexity genes (teal) have 7 or fewer
genes assigned to them.
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Figure 2.12 Distribution of gene complexity in response to high doses of
both perturbations.
Density plot of number of peaks per gene in retinoic acid (red) and TGF-β (blue, overlap
in purple) with median complexity marked by dotted line and high complexity cutoff
marked by solid line.
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Figure 2.13 Expression and peak width distributions in MCF-7 signal data
based on locus complexity.
(A) log2-transformed expression of low complexity (teal) and high complexity genes
(green) in response to retinoic acid (left) and TGF-β (right). P-values represent
the probability of these data or more extreme under the null hypothesis that the
distribution of gene expression values were drawn from the same probability
distribution via the Kolmogorov-Smirnov test.
(B) Distribution of peak widths for low complexity (teal) and high complexity (green)
peaks with the median peak width (151 base pairs) marked by the dotted black
line.
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Figure 2.14 Signaling shows less concordance between highly differentially
expressed genes and chromatin accessibility changes compared to
hematopoietic differentiation data for high complexity genes.
(A) Concordance between expression and accessibility changes between hematopoietic
stem and progenitor cells and monocytes. Left: plot showing changes in gene
expression in CD34+ hematopoietic stem and progenitor cells (blue) and CD14+
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monocytes (orange) from González et al., 2015 (schematic, top). For the plots, each
dot is a gene, and on the x axis is log2 fold change in expression and on the y-axis the
proportion of differentially accessible DHSs for each associated gene. The top 100
most highly expressed genes in hematopoietic stem and progenitor cells and
monocytes are colored in shades of orange and blue, respectively. Middle: density
plot of the distribution of the proportion of high complexity DHS associated with the
top 100 expressed genes in CD34+ hematopoietic stem and progenitor cells and
CD14+ monocytes with median value marked by vertical black line. Right: example
tracks DNase I sequencing data for KIT and CCR1 (marked on plot on left).
(B) Concordance between expression and accessibility changes between cells exposed to
ethanol vehicle control and high dose retinoic acid. Left: plot showing changes in
gene expression and chromatin accessibility between ethanol vehicle control and
high dose retinoic acid. Each dot is a gene, and on the x axis is the log2 fold change in
expression and on the y-axis the proportion of differentially accessible ATAC-seq
peaks for each gene. The top 100 most highly expressed genes in ethanol vehicle
control and high dose retinoic acid are colored in shades of gray and red,
respectively. Middle: density plot of the distribution of the proportion of high
complexity ATAC-seq peaks associated with the top 100 expressed genes in ethanol
vehicle control and high dose retinoic acid with median value marked by vertical
black line. Right: example ATAC-seq tracks of STRA6 and WNT11.
(C) Concordance between expression and accessibility changes between cells exposed to
ethanol vehicle control and high dose TGF-β. Left: plot showing changes in gene
expression and chromatin accessibility between ethanol vehicle control and high
dose TGF-β. Each dot is a gene, and on the x axis is the log2 fold change in
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expression and on the y-axis the proportion of differentially accessible ATAC-seq
peaks for each gene. The top 100 most highly expressed genes in ethanol vehicle
control and high dose TGF-β are colored in shades of gray and blue, respectively.
Middle: density plot of the distribution of the proportion of high complexity ATACseq peaks associated with the top 100 expressed genes in ethanol vehicle control and
high dose retinoic acid with median value marked by vertical black line. Right:
example ATAC-seq tracks of PMEPA1 and COL4A3.
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Figure 2.15 Concordance between gene expression change and proportion of
differentially accessible peaks per gene for high and low complexity genes
using a lower minimum coverage threshold for differential peaks.
(A) Concordance between expression and accessibility changes between cells exposed
to ethanol vehicle control and high dose retinoic acid. Left: plot showing changes
in gene expression and chromatin accessibility between ethanol vehicle control
and high dose retinoic acid for high and low complexity genes. Each dot is a gene,
and on the x axis is the log2 fold change in expression and on the y-axis the
proportion of differentially accessible ATAC-seq peaks for each gene. The top 100
most highly expressed genes in ethanol vehicle control and high dose retinoic
acid are colored in shades of gray and red, respectively. Right: density plot of the
distribution of the proportion of high complexity ATAC-seq peaks associated with
the top 100 expressed genes in ethanol vehicle control and high dose retinoic acid
with median value marked by vertical black line.
(B) Concordance between expression and accessibility changes between cells exposed
to ethanol vehicle control and high dose TGF-β. Left: plot showing changes in
gene expression and chromatin accessibility between ethanol vehicle control and
high dose retinoic acid for high and low complexity genes. Each dot is a gene, and
on the x axis is the log2 fold change in expression and on the y-axis the
proportion of differentially accessible ATAC-seq peaks for each gene. The top 100
most highly expressed genes in ethanol vehicle control and high dose retinoic
acid are colored in shades of gray and blue, respectively. Right: density plot of the
distribution of the proportion of high complexity ATAC-seq peaks associated with
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the top 100 expressed genes in ethanol vehicle control and high dose retinoic acid
with median value marked by vertical black line.
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Figure 2.16 Concordance between gene expression change and proportion of
differentially accessible peaks per gene for low complexity genes.
Concordance between expression and accessibility changes between hematopoietic stem
and progenitor cells and monocytes, ethanol control and high dose retinoic acid, and
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ethanol control and high dose TGF-β. Left: For the plots, each dot is a gene, and on the x
axis is log2 fold change in expression and on the y-axis the proportion of differentially
accessible DHSs/peaks for each associated gene. Right: density plot of the distribution of
the proportion of high complexity DHS or peaks associated with the top 100 expressed
genes in either condition with median value marked by vertical black line.
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Figure 2.17 Separation of differentially expressed genes in response to signal
into high and low concordance groups shows differences in pre-existing
accessibility.
(A) Categorization of differentially expressed genes in response to high dose retinoic acid
based on direction of expression change and proportion of peaks differentially
accessible in the same direction.
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(B) Categorization of differentially expressed genes in response to high dose TGF-β
based on direction of expression change and proportion of peaks differentially
accessible in the same direction.
(C) Differential accessibility in ethanol vehicle control conditions prior to addition of
high dose retinoic acid. Accessibility of every peak assigned using the ‘nearest’
approach for gene groups from (a) in ethanol vehicle control conditions. P-values
represent the probability of these data or more extreme under the null hypothesis
that the distribution of peak accessibilities were drawn from the same probability
distribution via the Kolmogorov-Smirnov test.
(D) Differential accessibility in ethanol vehicle control conditions prior to addition of
high dose TGF-β. Accessibility of every peak assigned using the ‘nearest’ approach for
gene groups from (b) in ethanol vehicle control conditions. P-values represent the
probability of these data or more extreme under the null hypothesis that the
distribution of peak accessibilities were drawn from the same probability distribution
via the Kolmogorov-Smirnov test.
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Figure 2.18 Accessibility-concordant and accessibility-non-concordant genes
have similar loci complexity and differences in peak accessibility after
exposure to signal depending on change in gene expression.
(A) Distribution of loci complexity the four groups of genes with differential
expression in response to high dose retinoic acid.
(B) Distribution of loci complexity the four groups of genes with differential
expression in response to high dose TGF-β.
(C) Accessibility after exposure to high dose retinoic acid. Accessibility of every peak
assigned using the ‘nearest’ approach for gene groups based on accessibility
concordance. P-values represent the probability of these data or more extreme
under the null hypothesis that the distribution of peak accessibilities were drawn
from the same probability distribution via the Kolmogorov-Smirnov test.
(D) Accessibility after exposure to high dose TGF-β. Accessibility of every peak
assigned using the ‘nearest’ approach for gene groups based on accessibility
concordance. P-values represent the probability of these data or more extreme
under the null hypothesis that the distribution of peak accessibilities were drawn
from the same probability distribution via the Kolmogorov-Smirnov test.
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Figure 2.19 Multiple approaches to quantifying peak accessibility shows low
correlation between gene expression changes and accessibility changes in
signaling.
(A) ‘Nearest’ approach to assigning peaks to genes shows less concordance in signaling
compared to hematopoietic differentiation. Left: schematic showing ‘nearest’
approach where peaks are assigned to the nearest transcriptional site and change in
accessibility (purple) on a per-gene basis is calculated by either median change in
accessibility (top row) or maximum peak change (bottom row). Right: scatter plots
showing change in peak accessibility (median or maximum) versus log2 fold change
in expression on y axis for hematopoietic differentiation data from González et al.
(left column) and for high dose retinoic acid and high dose TGF-β (right two
columns). Pearson’s correlation coefficients reported with 95% confidence interval
from bootstrapping with 10,000 replicates in parentheses.
(B) ‘Window’ approach to assigning peaks to genes shows less concordance in signaling
compared to hematopoietic differentiation. Left: schematic showing ‘window’
approach where all peaks within a certain window of the the transcriptional start site
are assigned to that gene and the change in accessibility (purple) on a per-gene basis
is calculated by the median change in accessibility (top row) or the maximum change
in accessibility (bottom row). Right: scatter plots showing change in peak
accessibility (median or maximum) using ‘window’ approach with a 100 kilobase
window versus log2 fold change in expression on y axis for hematopoietic
differentiation data from González et al. (left column) and for high dose retinoic acid
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and high dose TGF-β (right two columns). Pearson’s correlation coefficients reported
with 95% confidence interval from bootstrapping with 10,000 replicates in
parentheses.
(C) Using ‘nearest’ approach to look for correlation between accessibility and gene
expression changes based on annotations of peak location. First two columns
showing correlation for hematopoietic differentiation data from González et al, and
right four columns showing correlation for high dose retinoic acid and high dose
TGF-β, respectively. Pearson’s correlation coefficients reported with 95% confidence
interval from bootstrapping with 10,000 replicates in parentheses.
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Figure 2.20 Effect of window size on number of differentially accessible
peaks based on gene expression change and correlation of gene expression
and accessibility changes using medium and low dose signals.
(A) Distributions of number of differentially accessible peaks for differentially
expressed and non-differentially expressed genes in response to high dose
retinoic acid (left) or high dose TGF-β (right) based on window size around
transcriptional start site (TSS).
(B) ‘Nearest’ approach to assigning peaks to genes shows less concordance in
signaling compared to hematopoietic differentiation. Scatter plots showing
change in peak accessibility (median or maximum) versus log2 fold change in
expression on y axis for medium and low dose retinoic acid (first two columns)
and medium and low dose TGF-β (second two columns). Pearson’s correlation
coefficients reported with 95% confidence interval from bootstrapping with
10,000 replicates in parentheses.
(C) ‘Window’ approach to assigning peaks to genes shows less concordance in
signaling compared to hematopoietic differentiation. Scatter plots showing
change in peak accessibility (median or maximum) versus log2 fold change in
expression on y axis for medium and low dose retinoic acid (first two columns)
and medium and low dose TGF-β (second two columns). Pearson’s correlation
coefficients reported with 95% confidence interval from bootstrapping with
10,000 replicates in parentheses.
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Figure 2.21 Focusing on peaks annotated for biologically relevant
transcription factor motifs fails to demonstrate a strong correlation
between the magnitude of gene expression and chromatin accessibility
changes.
(A) Peaks annotated for motifs of transcription factors related to retinoic acid biology
(RAR-α, HOXA13, FOXA1, left column) showed weak correlation between
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changes in gene expression and chromatin accessibility in response to high dose
retinoic acid. Peaks are colored based on the log-odds of a motif being present in
a given peak. Plot of expression and accessibility change for 5000 randomly
sampled peaks lacking the corresponding peak (right column). Pearson’s
correlation for peaks not having a given motif are for all peaks without that motif,
not the 5000 subsampled peaks. Pearson’s correlation coefficients reported with
95% confidence interval from bootstrapping with 10,000 replicates in
parentheses.
(B) Peaks annotated for motifs of transcription factors related to retinoic acid biology
(SMAD3, SMAD4, SMAD9, left column) showed weak correlation between
changes in gene expression and chromatin accessibility in response to high dose
TGF-β. Peaks are colored based on the log-odds of a motif being present in a
given peak. Plot of expression and accessibility change for 5000 randomly
sampled peaks lacking the corresponding peak (right column). Pearson’s
correlation for peaks not having a given motif are for all peaks without that motif,
not the 5000 subsampled peaks. Pearson’s correlation coefficients reported with
95% confidence interval from bootstrapping with 10,000 replicates in
parentheses.

66

CHAPTER 3: DETERMINING DRIVERS OF A RARE, EARLY-INVADING
SUBPOPULATION OF CLONAL MELANOMA CELLS
3.1 Introduction
A devastating feature of many cancers, including cutaneous melanoma, is the ability of
cells to metastasize to distant sites, gain a foothold and begin rapidly dividing, and,
eventually, disrupt end organ function at the site of metastasis, making metastasis a
large factor in cancer morbidity and mortality. Metastasis involves rare cells in the
primary tumor to undergo multiple molecular and behavioral changes to first become
invasive to leave the tumor and travel via the bloodstream or lymphatics, establish itself
at a new site, and then revert to a proliferative state to create the metastasis (Mittal
2018; Mani et al. 2008; Francí et al. 2006; Polyak and Weinberg 2009). While there has
been previously established roles for the local tumor microenvironment or cell-intrinsic
factors like mutations for invasive behavior in metastasis (Olmeda et al. 2017; Kaur et al.
2019; Nataraj, Marrocco, and Yarden 2021; Nguyen et al. 2022), more recently, the role
of non-genetic, cell-intrinsic factors have been implicated (Arozarena and Wellbrock
2019; Quinn et al. 2021). What is unclear is the role that single cells have in initiating
phenotype switching within the primary tumor to begin invasion and dissemination of
the tumor. Namely, are the rare cells that are able to leave the primary tumor and invade
other tissues intrinsically primed to do so (Quinn et al. 2021), do they leave because of
external factors such as their local microenvironment (Kaur et al., 2019; Olmeda et al.
2017), or some combination of the two?
Genetic differences such (i.e., mutations) have often been implicated in driving the
transition to a more invasive state underlying metastasis (Nataraj et al., 2021; Nguyen et
al., 2022). However, recent work has established the role of non-genetic changes in
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regulatory pathways to cause the switch to an invasive phenotype (Arozarena and
Wellbrock, 2019; Quinn et al., 2021). For example, this phenotype switching in
melanoma is driven by changes in Wnt pathway signaling and by factors in the local
tumor milieu.
Here, we show that within clonal melanoma cell lines there are rare and highly
invasive subpopulations. Moreover, this phenotype is transient and marked by the
expression of SEMA3C. The transcription factor NKX2.2 also negatively regulates the
formation of the invasive subpopulation.
3.2 Results
3.2.1 SEMA3C marks a rare and invasive population
Invasiveness of cells was measured using polytetrafluoroethylene transwells and a serum
gradient to encourage invasion. The so-called early invading cells are the small
percentage of cells that invade through the transwells in the first 8 hours of the assay
(Figure 3.1). To identify a candidate marker of the behavior, early invading cells, lateinvading cells, and non-invading cells had their transcriptomes profiled via RNA
sequencing. SEMA3C, a gene whose protein product is expressed on the cell surface, was
identified as a differentially expressed gene that marked early invading cells (Figure
3.2). To establish SEMA3C as a bona fide marker of the early invading population, cells
were sorted based on the degree of SEMA3C expression using flow-assisted cell sorting
(Figure 3.3) and their rate of invasiveness was measured using the transwell assay. In
fact, SEMA3C-high cells were far more invasive than SEMA3C-low cells and the overall
population (Figure 3.4), suggesting SEMA3C is a marker of the early-invading
population.
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3.2.2 NKX2.2 is a transcription factor that promotes the invasive
subpopulation
ATAC-sequencing was performed on early-invading, late-invading, and non-invading
FS4 cells to characterize differences in chromatin accessibility and identify putative
regulatory factors. Overall, a relatively small amount (1107) of differential peaks were
identified that characterized the early-invading population. The homeobox-domain
containing transcription factor NKX2.2 (also commonly referred to as NKX2-2) was
identified as a putative regulator of the early-invading phenotype. To test the role of
NKX2-2 in creating an early invading subpopulation, we knocked it out using CRISPRCas9-mediated genome editing. Much to our surprise, rather than making cells less
invasive as we hypothesized, knockout of NKX2-2 caused 1205Lu cells to become more
invasive and proliferate at a faster rate (Figure 3.5). Principal component analysis of
RNA and ATAC-sequencing data demonstrated that cells with an active guide targeting
NKX2-2 separately in principal component space for both data modalities (Figure 3.6).
While there was some overlap in the transcriptional profile between NKX2-2 knockout
1205Lu cells and early invading 1205Lu and FS4 cells (Figures 3.6, 3.7, 3.8, 3.9), the
knockout cells were still transcriptionally distinct. Most of the common differentially
expressed genes were those downregulated in early invaders and in NKX2-2 knockout
cells which were genes involved in cell migration, cell motility, and extracellular matrix
organization (Figure 3.10).
3.3 Discussion
Overall, these findings indicate that clonal melanoma cells can have a cell-intrinsic, nongenetic ability to become invasive. This rare population in our system is characterized by
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high expression of the surface protein SEMA3C and enrichment for cells highly
expressing SEMA3C enriches for invasive cells. This work also establishes the foundation
for NKX2.2 as a regulator of invasive behavior in melanoma. This is result is particularly
interesting given that to date the only mention of NKX2.2, which has been implicated in
Ewing Sarcoma, and melanoma is an immunohistochemical study mentioning that 2/6
melanoma samples stained positive for NKX2.2 (Yoshida et al. 2012). Future work
should better delineate the mechanism by which NKX2.2 increases both invasiveness
and proliferation and look to recapitulate these results in vivo.
3.4 Contributions
This chapter contains quotes and figures from Kaur et al. published in 2022 in BioRxiv
(Kaur et al. 2022). AK, designed, performed and analyzed all experiments. KK curated
and performed all analysis on sequencing data generated by AK. Figures 3.1, 3.3, 3.4, and
3.5 were made by AK, while the rest of the figures and associated analyses mentioned in
this chapter were done by KK.
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Figure 3.1 A rare, early invading subpopulation of cells is prime for invasion
Schematic showing the transwell assay with definitions of different invasive cell
populations and their relative proportions of the total population for the FS4 cell line.
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Figure 3.2 RNA-sequencing establishes SEMA3C as a potential marker of the
early-invading population
Heatmap showing all differentially expressed genes (including SEMA3C) between earlyinvading and non-invading FS4 melanoma cells.
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Figure 3.3 Fluorescence-activated cell sorting (FACS) of a 1205Lu melanoma
cells based on SEMA3C protein expression
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Figure 3.4 FS4 cells highly expressing SEMA3C are more invasive
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Figure 3.5 NKX2.2 negatively regulates both invasive and proliferative
behaviors in 1205Lu melanoma cells
1205lu melanoma cells expressing either AAVS or NKX2.2 knockout were seeded on the
transwell and the number of invading cells was calculated (left). 1205lu melanoma cells
expressing either AAVS or NKX2.2 knockout were seeded in tissue culture plates and
cells were allowed to grow for 10 days. Cells were imaged every 24 hours and cell counts
at different times were determined and used to calculate growth rate of the cells (right).
Error bars represent standard error across 3 replicates.
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Figure 3.6 NKX2.2 knockout cells cluster separately in principal component
space using gene expression and chromatin accessibility data
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Figure 3.7 Pairwise distance metrics show that NKX2.2 knockout cells are
most similar to 1205Lu early and late invaders.
Matrix of distance (measured by 1 - Pearson’s r) between samples’ expression for the
union of differentially expressed genes between both cell lines
when comparing early invaders to non-invaders.
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Figure 3.8 Differentially expressed genes show some overlap between cell
lines and early-invading cells and NKX2.2 knockout cells
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Figure 3.9 Odds ratio analysis looking at similarity of NKX2.2 knockout cells
to 1205Lu and FS4 early invaders

79

Figure 3.10 Overrepresentation analysis of genes differentially
downregulated after NKX2.2 knockout.
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS
In the work presented in this thesis through two different projects, I both used existing
bioinformatic approaches and developed computational techniques to better understand
principles of gene regulation both more broadly in the context of response to singlefactor perturbations as well as in the context of distant metastasis in melanoma. A
systematic analysis of tandem, bulk RNA-seq and ATAC-seq demonstrated that the
changes in gene expression from signals such as retinoic acid or TGF-β were not
necessarily concordant with changes in chromatin accessibility. Moreover, the genes
which had concordant changes between chromatin accessibility and gene expression
tended to be less accessible prior to stimulation with signal. Further analysis using
multiple types of assigning peaks and subsetting peaks based on computationally
predicted transcription factor activity failed to demonstrate any further indication of
concordance. These results suggest that at least in the context of these two signals, there
are two modes of regulation at play. However, questions remain whether and to what
degree these findings hold in other systems and contexts.
Additionally, we identified a highly invasive subpopulation within clonal melanoma cell
lines that are marked with the transient, high expression of SEMA3C. This
subpopulation was shown to drive the distant metastasis, (i.e., those beyond local lymph
nodes) in mouse models of melanoma. Using bioinformatic analyses we identified the
transcription factor NKX2.2 as a possible regulator of this invasive state and that its
knockout created highly invasive cells. Further studies should better elucidate this
factor's role more mechanistically as well as characterize what role it has in metastasis in
vivo.
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4.1 Determining which peaks interact with which genes
Finding which gene(s) a given region of accessibility interacts with is by no means a
trivial task. Here, we adopted two different heuristics to map peaks to genes. The first,
commonly used both in ATAC-seq and other peak-based genomic profiling methods (Li
et al. 2012; Nair et al. 2021) is to simply find the nearest transcription start site and
assign the peak to that gene. This creates a one-to-one peak to gene mapping, but since
this linear approach fails to take into account the three-dimensional conformation of
chromatin and the long range contacts that may occur, we also used a window-based
approach. This took every peak within a window around the transcriptional start site
creating a many-to-one mapping. However, this method also has its own shortcomings
given that certain enhancers, like the sonic hedgehog limb-bud-specific enhancer, can act
from over 850 kilobases away (Lettice et al. 2003), much farther away than our largest
window of 100 kilobases. Current work involves leveraging deep learning architectures,
especially convolutional neural nets to infer from sequence alone cis-regulatory
elements, predicted transcription factor binding sites, and higher order transcription
factor “syntax” (Vaishnav et al. 2022; de Almeida et al. 2022; Novakovsky et al. 2022).
While the use of these machine learning-based approaches is still in its infancy, the
findings from these studies and further refinements may create better mappings with
which to infer concordance.
Alternatively, there are other approaches that can be invoked to further elucidate
a given peak’s contribution to gene expression change. For example, Weissman and
colleagues developed a technique which correlated peaks and the eigenvector of this
correlation matrix, named “eigenpeaks”, on a gene-by-gene basis. Then, eigenpeaks were
correlated with gene expression. This method reduces the covariance of multiple peaks
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nearby into one value, and there was rarely more than one eigenpeak per gene,
indicating that nearby cis-regultory elements typically act in concert in their system
(Mold et al. 2022). Moreover, ArchR, a software package developed for single-cell
chromatin accessibility analysis tested over 50 models to create a gene score from
chromatin accessibility data. The highest scoring models tested on data from bone
marrow and peripheral blood monocyte samples used signals from the promoter and
gene body and used an exponential decay function to weight the contribution of more
distal regulatory elements (Corces et al. 2018). Finally, Cicero, which was also developed
for single-cell chromatin accessibility data, uses a combination of co-accessibility
correlations with a graphical LASSO and distance penalty to infer a cis-regulatory map
(Pliner et al. 2018). While Cicero in theory could be adapted to bulk chromatin
accessibility data, it may not be as effective given the model assumes input from many
cells rather than the usually limited number of samples done in bulk studies, but its
tractability for this purpose should be explored.
Finally, peak-gene pairs can be further informed from topologically associating
domains (TADs) measured by Hi-C. However, TAD boundaries are not always
informative of gene expression relationships and the disruption of TAD boundaries does
not necessarily have an effect on gene expression or development phenotypes (Despang
et al. 2019; Ghavi-Helm et al. 2019; Paliou et al. 2019; Williamson et al. 2019; Tena and
Santos-Pereira 2021). Furthermore, TAD boundaries are not as stable as previously
thought as studies in cancer have demonstrated that reprogramming of binding sites and
TAD boundaries is a hallmark of therapy resistance in multiple systems (AchingerKawecka et al. 2020; Zhou et al. 2022). A possible “gold-standard” approach to
definitively establish accessible peak to gene mappings is to use tandem RNA-seq and
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ChIP-seq or HiChIP for the transcription factor(s) of interest to a signaling process along
with ATAC-seq. However, the scale and cost of this kind of experiment is significant and
can suffer from technical shortcomings of the ChIP-seq/HiChIP techniques in that they
are heavily reliant on the affinity of available antibodies for a protein of interest and that
each experiment can only interrogate one protein at a time and do not identity
interacting proteins that often work in tandem in the regulatory complex. Furthermore,
the downstream analysis, like many multi-omics analyses, is by no means
straightforward.
4.2 Applying findings related to chromatin accessibility and gene expression
to single-cell technologies
The observant reader of this dissertation (and bless you if you have made it this far) will
notice that thus far in the discussion of concordance of chromatin accessibility and gene
expression measurements, there has been little to no mention of single-cell technologies.
Recent advances in barcoding, microfluidics, and robotics have made both scRNA-seq
and scATAC-seq as well as both assays in tandem far more straightforward to perform
and the results more reproducible. However, as these technologies are still nascent, the
sparsity of data produced due to technical dropouts as well as issues with separating
biological variation from technical artifacts and batch effects makes it difficult to more
systematically analyze concordance between these data (Minnoye et al. 2021). The recent
introduction of the Chromium Single Cell Multiome ATAC + gene expression kit (10X
Genomics, Pleasanton, CA) has proved to be exciting in that it allows for simultaneous
measurements of gene expression and chromatin accessibility in the same cell. However,
this method is still somewhat hampered in that gene expression measurements are
restricted to nuclear transcripts only.
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Despite these limitations, there is reason for optimism that future work looking
to determine concordance at a single cell resolution will be more tractable. First, singlecell technologies are improving in their accuracy and precision rapidly as a result of
constant innovation. For example, very recent work by Chen and colleagues have
established a new method, sequencing of nuclear protein epitope abundance, chromatin
accessibility, and the transcriptome in single cells (NEAT-seq). NEAT-seq is able to
interrogate all tenets of the central dogma of biology, and as a test case, NEAT-seq was
used to identify transcription factors with regulatory activity in creating specific T-cell
subsets (A. F. Chen et al. 2022). Furthermore, there is some indication that ‘pseudo-bulk’
accessibility profiles, i.e. those created from combining the sparse data from all members
of the same cluster in low dimensional space can recapitulate accessibility profiles from
bona fide bulk experiments (Minnoye et al. 2021), but this assumption needs to be more
rigorously examined. Another intriguing future direction is to create pseudo-bulk
profiles from a multiome experiment and compare the results of the concordance
analyses presented in this dissertation to one done in the same system using true bulk
sequencing data.
4.3 Further considerations for future work examining concordance
4.3.1 Expanding the palette of transcription factors
Here, we examine the activity of two groups of transcription factors related to the
biological signaling of the two perturbations used. As a result, our findings are relevant
to the transcriptional effectors of retinoic acid (retinoic acid receptor α and HOX family
transcription factors) and TGF-β (SMAD transcription factors) within the context of
MCF-7 breast cancer cells being exposed to these signals for approximately three days.
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There is no guarantee that other transcription factors would behave similarly within this
system, and it remains largely unknown what may happen if one were to interrogate the
effects of varying systems, perturbations or time scales. Indeed, as established here and
previously, within the context of developmental signals there often is far more
concordance between chromatin accessibility changes and gene expression. Along with
these findings is the fact that there are lineage defining transcription factors that are able
to bind to inaccessible chromatin and make the chromatin accessible for itself and other
factors to bind, the so-called pioneer factors (Zaret 2020). Among these are members of
the fork head box (FOX) family and GATA family members, and surely the relationship
of concordance when examining these factors would be different than our findings.
Alternatively, there is a body of work demonstrating that some factors depend
heavily on the pre-existing chromatin accessibility landscape for their binding. For
example, the glucocorticoid receptor binds almost exclusively to pre-existing accessible
chromatin prior to stimulation with dexamethasone (John et al. 2011), and that activator
protein 1 (AP-1) establishes this binding pattern for the glucocorticoid receptor by
maintaining chromatin accessibility (Biddie et al. 2011). Similarly, the lineage-defining
transcription factor Foxp3 binds to preformed accessible sites established by its
structural homolog, Foxo1, to establish regulatory T cell identity (Samstein et al. 2012).
Of note, this process of regulatory T cell specification via Foxp3 is considered a ‘late
differentiation’ process, as the precursor cell state, the mature naive CD4+ T cell is
considered mature. These studies looked at chromatin accessibility data along with
ChIP-seq data of the factor of interest, and further work looking to examine concordance
in these contexts should also include transcriptomic data. Thus, there is a need to further
examine a variety of factors in a variety of contexts using approaches established in this
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dissertation as a starting framework to gain a better understanding which underlying
regulatory relationships are more unique to specific contexts and which are more general
principles of eukaryotic gene regulation.
Finally, a limitation of the findings in the above work is that they are from a
clonal cell line system. Further studies should investigate to what degree our findings are
applicable to in vivo systems responding to physiologic situations. Indeed, some work
has demonstrated similar findings to ours from primary placental tissue samples (Starks
et al. 2019). A particularly promising primary system are cells from the peripheral
immune compartment as they are often poised to react quickly to signals such as
lipopolysaccharide, and primary cells are relatively straightforward to collect and
manipulate ex vivo. Another often overlooked opportunity due to a bias toward
mammalian and yeast systems for examining eukaryotic gene regulation is to examine
concordance between chromatin accessibility and gene expression within the plant
kingdom. In fact, there exists some precedent of this in the literature, especially using
the model system Arabidopsis thaliana (Farmer et al. 2021). The wide array of
aneuploidy in plant genomes as well as the rich array of physiological process that
requires precise transcriptional regulation such as flowering, phototropism, and
thigmotropism, to name a few, present an invaluable opportunity to better understand
eukaryotic gene regulation.
4.3.2 The issue of timing
In our work, MCF-7 cells were continuously exposed to perturbations for 72 hours and at
the end of this time period cells were split into two pots for either chromatin accessibility
or gene expression measurements. The underlying assumption of this approach is that
72 hours of continuous exposure is sufficient to induce all changes in gene expression
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and chromatin accessibility to measure. Other groups (Hota et al. 2022; Ramirez et al.
2017; Bunina et al. 2020) have instead used serial measurements at multiple time points
after a perturbation and looked at the concordance between changes in chromatin
accessibility at a given time point and gene expression at a later time point. Whether or
not the assumption of ordinality of accessibility change to expression change is correct is
subject to debate and may miss secondary changes to chromatin accessibility in response
to gene expression changes. However, this more temporally aware approach is
nonetheless important, and care should be taken to consider these dynamics when
examining concordance in the future.
4.3.3 Disentangling possible confounding effects due to the cell cycle
As many studies, including our own, examine or will examine the concordance between
these data in actively cycling cells, it is important to remember that during the process of
mitosis, transcription is halted, chromatin condenses into chromosomes in anticipation
of metaphase and the resulting progeny must re-establish at least part of the
transcriptional program of their antecedents. Cell cycle can indeed be such an important
confounder that scRNA-seq analyses routinely regresses out the effect of cell cycle based
on transcriptionally inferred cell cycle scores (Nestorowa et al. 2016). Further work
should be done to consider what effect, if any, this may have on our findings. A
considerable body of work exists on “mitotic bookmarking,” or the retention of specific
transcription factors at target loci on mitotic chromosomes such that the necessary
transcriptional information can be propagated to progeny (Zaidi et al. 2010; Teves et al.
2016). Hsiung and colleagues used a murine erythroblast model to compare chromatin
accessibility between cells undergoing mitosis and those in interphase to demonstrate
that chromatin accessibility at the macromolecular level is largely independent of cell
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cycle (Hsiung et al. 2015). However, future work has to consider whether or not that is
the case for the system of interest as well as whether any transcription factors salient to
the biological questions are likely to be retained for bookmarking or evicted during
mitosis.
4.3.4 Transcription factor footprinting in chromatin accessibility data
A commonly cited limitation of methods for measuring chromatin accessibility genomewide is that inferring the specific transcription factor bound to an accessible region from
these data is non-trivial. Thus, it is necessary to corroborate findings with further
mechanistic studies including, but not limited to, genetic perturbation of transcription
factors, ChIP-seq, or measuring of nascent RNA (Minnoye et al. 2021). There are also
more technical considerations for transcription factor footprinting. Historically, DNaseseq has continued to outperform ATAC-seq for transcription factor footprinting (Sung,
Baek, and Hager 2016), but more recent advances have begun to also better adapt
footprinting for ATAC-seq, including better modeling the effects of Tn5 transposase bias
(Karabacak Calviello et al. 2019). Regardless of modality, to accurately identify
transcription factor binding, libraries produced must be sequenced at a great depth.
Thus, with the current state of the art, there are limitations in inferring the activity of
transcription factors using accessibility data.
5.3.5 An accessible peak does not a site of transcription make
Another important level of transcriptional regulation not addressed in the contents of
Chapter 2 are the host of the post-translational modifications, including methylation,
acetylation, phosphorylation, methylation, SUMOylation, among others (Strahl and Allis
2000). By altering the electronic charge of histone tails, these modifications can alter the
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binding of histone tails to DNA and therefore gene expression (Kouzarides 2007; Yanjun
Zhang et al. 2021).
Of note is histone acetylation, which reduces the positive charge of lysine
residues in the histone tail, leaving DNA exposed (Bannister and Kouzarides 2011). Thus,
histone acetylation is often considered an active histone mark (Pogo, Allfrey, and Mirsky
1966; Clayton et al. 1993). While many lysine residues can be acetylated, the acetylation
of the 27th residue of histone 3 (H3k27ac) is of particular interest because it is often
localized at promoters and enhancers of actively transcribed genes (Creyghton et al.
2010; Rada-Iglesias et al. 2011).
H3K27ac histone modifications are recognized by the p300/cyclic AMP response
element-binding protein (CBP) activating protein complex. The p300/CBP complex can
then relax chromatin structure at promoters through its intrinsic histone
acetyltransferase activity as well as recruiting other acetyltransferases (Q. Jin et al. 2011).
Bromodomain and extraterminal domain (BET) proteins also recognize the H3k27ac
using their bromodomains and act as scaffolds to recruit other transcription factors and
RNA polymerase II to modulate gene expression (Josling et al. 2012; Taniguchi 2016;
Benton, Fiskus, and Bhalla 2017).
While in many cases the result of increased H3K27 acetylation is more accessible
chromatin and increased gene expression, the exact interplay between these so called
“epigenetic” marks is far more complicated. Recent work has only begun to interrogate
enhancer elements using an activity-by-contact model along with CRISPRi to test
enhancer-gene interactions in 30 genes (Fulco et al. 2019). Future work should expand
these methodologies to more genes in more context as well as more rigorously build a
model of gene regulation by examining changes not only in gene expression and
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chromatin accessibility, but also using localization of important transcription factors and
histone modifications.
4.5 Single-cell variability in melanoma metastatic potential
4.5.1 Further characterization of NKX2.2 deficient cells
One of the most stark findings by Kaur and colleagues was that the rare and transient
population of highly invasive cells characterized by high SEMA3C expression composed
the vast majority of melanoma cells that migrated from the primary tumor and
metastasized in the lung (Kaur et al. 2022). Furthermore, NKX2.2 was identified from
ATAC-seq data in the FS4 cell line (cf. the 1205 Lu cell line that in vivo and CRISPRCas9 knockout studies were done) for characterizing early invading cells. The initial
hypothesis was that knock down of this factor whose motif was overrepresented in peaks
differentially accessible in early invading cells would lead to loss of the invasive
phenotype. Much to our surprise, it not only increased invasiveness, but it also starkly
increased the rate of cell proliferation. This finding is notable given that previous
literature in melanoma had demonstrated a trade-off or anti-correlation between
invasiveness and proliferation, meaning an increase in one attribute usually comes at the
price of a decrease in another (Hoek et al. 2006, 2008). Indeed this tradeoff paradigm
has been adopted from pareto optimality theory in economics (Debreu 1954) and been
applied to biology and division of cellular tasks (Riolo et al. 2013; Hart et al. 2015).
Further transcriptional profiling of NKX2.2 knockout melanoma cells may lend insights
into a possible edge case where the rules of pareto optimality may fail. Furthermore,
while proliferation and invasiveness increased as a result of knockout using functional
assays in vitro, an important and logical next step is to adopt an experimental schema
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similar to the previously mentioned one which Kaur and colleagues used to demonstrate
the invasive potential of cells highly expressing SEMA3C in vivo. It is important to
recapitulate similar results using a mixture of NKx2.2 deficient and control cells in
murine models to further establish the role of NKX2.2 as a bona fide regulator of this
rare, invasive state.
4.5.2 Elucidating the role and mechanism of NKX2.2
Our work used a systems biology approach to identify NKX2.2 as a regulator of the early
invading phenotype. However, further work is necessary to more mechanistically
characterize what role, if any, NKX2.2 has in creating this invasive and proliferative
phenotype and understanding its relevance to disease pathogenesis. It is promising that
there is considerable overlap in genes downregulated in NKX2.2 knockout cells
compared to safe harbor controls and those downregulated early invaders versus noninvaders. This seems to indicate that at least in this aspect, the downregulation of a
similar set of genes related to cell migration and the extracellular matrix have their
expression modulated by NKX2.2. As a homeobox domain-containing protein, NKX2.2
is most commonly implicated in the morphogenesis of the central nervous system
(Lovrics et al. 2014) and pancreatic beta cell function (Raum et al. 2006), but there is a
dearth of literature on the transcription factors role in cancer, especially in the context of
melanoma. Interestingly, while NKX2.2 is implicated as necessary for oncogenic
transformation in Ewing’s sarcoma with an EWS/FLI fusion (Smith et al. 2006), the only
mention of NKX2.2 and melanoma in the literature to the best of my knowledge is a
paper demonstrating NKX2.2 as a useful immunohistochemical marker of Ewing
sarcoma. This study looked at other small round cell tumors and noted that 2/6 of
malignant melanomas tested also stained positive for NKX2.2 (Yoshida et al. 2012),
92

indicating that as far as NKX2.2 and melanoma are concerned, we are in terra incognita.
A useful first step is to more definitively look at binding of NKX2.2 in both bulk and
highly invasive populations using ChIP-seq or HiChIP. While these techniques are by no
means trivial, they would identify binding and long-range interaction patterns in these
cells to begin to establish the NKX2.2 regulome specifically in melanoma and melanoma
metastatic potential.
4.6 Concluding remarks
Throughout the course of this dissertation, I have demonstrated through systematic
analysis of chromatin accessibility and gene expression data that there are two distinct
groups of gene expression changes in response to single-factor perturbations: those with
concordant accessibility changes and those without. The proposed future experiments
would explore how these results hold in other systems or for other transcription factors.
Finally, I have begun to lay the foundation of the role of the transcription factor NKX2.2
in invasive behavior in melanoma metastatic melanoma. Taken together, these findings
will not only help better delineate the fundamental regulatory axioms at play in
transcriptional regulation, but also help deliver insights to help inform stem cell-based
therapeutics and more effective cancer therapies.
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CHAPTER 5: MATERIALS AND METHODS

5.1 PCA of RNA and ATAC-sequencing samples
Principal component analysis and visualization of RNA-seq and ATAC-seq samples was
performed using raw counts and performing a variance stabilizing transform. Results
were visualized using functions from the R DESeq2 package (Love, Huber, and Anders
2014).
5.2 Bulk RNA-sequencing analysis
Initial RNA sequencing analysis was performed as previously (Goyal et al. 2021). Briefly,
reads were aligned to the hg38 assembly using STAR v.2.7.1a and counted uniquely
mapped reads with HTSeq v0.6.1 and hg38 GTF file from Ensembl (release 90). We used
DESeq2 v1.22.2 in R 3.5.1 using a minimum absolute-value log-fold-change of 0.5 and a
q value of 0.05. For genes with multiple annotated transcriptional start sites, we used the
‘canonical’ transcription start site from the knownCanonical table from GENCODE v29
in the UCSC Table Browser.
We performed functional over-representation and gene set enrichment analysis
(Subramanian et al, 2005) of upregulated transcripts in the high dose retinoic acid and
high dose TGF-β using clusterProfiler v4.0.5 and enrichplot v1.12.3 (T. Wu et al. 2021). P
values for the over-representation analysis were adjusted using a false discovery rate
approach. We used the C5 ontology and H hallmark curated gene sets from the
Molecular Signatures Database (MSigDB) v7.4 (Liberzon et al. 2011, 2015) as reference
gene sets to compare our upregulated genes to.
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5.3 ATAC-sequencing analysis
ATAC-seq alignment and peak calling was performed as previously (Sanford et al, 2020).
We aligned peaks to the hg38 assembly using bowtie2 v2.3.4.1, and filtered out lowquality alignments with samtools v1.96, removed duplicate read pairs with picard 1.96,
and used custom Python scripts along with bedtools v2.25.0 to create alignment files
with inferred Tn5 insertion points. We called peaks using MACS2 (Zhang et al. 2008)
v2.1.1.20160309 with the command, ‘macs2 callpeak --nomodel --nolambda --keep-dup
all --call-summits -B --SPMR --format BED -q 0.05 --shift 75 --extsize 150’.
Since we had three biological replicates per condition, we used a majority rule
approach to retain only summits that were found in at least two replicates (Yang et al.
2014). Using these condition-specific peak files, we used bedtools to create a consensus
peak file by merging each individual condition's peak summit file together in a manner
that disallowed overlapping peaks. We used bedtools merge command ‘bedtools merge d 50’ to combine features within 50 base pairs of each other into a single peak after
testing multiple merge distances. We used the number of ATAC-seq fragment counts at
each peak in this merged consensus peak file for differential peak analysis.
We used the custom peak analysis algorithm from Sanford et al., 2020 that took
advantage of additional ethanol control conditions to estimate false discovery rate in
ethanol controls to then identify differential peaks. Briefly, reads were quantified for
each peak in the master consensus file and fragments at each peak were normalized to
correct for differences in total sequencing depth using the equation:
sample's total reads in peaks/mean number of reads in peaks across all samples. Next,
an estimated false discovery rate was calculated in each cell of a 50x50 grid containing
50 exponentially-spaced steps of minimum fold-change values (ranging from 1.5-10) and
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50 exponentially-spaced steps of minimum number of normalized fragment counts in
the condition with the greater number of counts (ranging from 30 to 237 or 10 to 237).
The estimated false discovery rate (FDR) was calculated using the equation: estimated
FDR = (no. of conditions)(est. number of false positive peaks per condition)total number
of differential peaks in experimental conditions. After calculating the estimated FDR in
each cell of the 50x50 grid, we then pooled together differential peaks contained in any
cell with an FDR less than 0.25%.
We performed motif analysis on our set of differential peaks using chromVAR
v1.8.0 (Schep et al. 2017), its associated cisBP database of transcription factor motifs,
and the motifmatchR package from bioconductor. To decrease the variance of the
transcription factor motif deviations scores, we pooled together the different dosages of
retinoic acid or TGF-β. The chromVAR code was modified to extract an internal metric
that equals the fractional change in fragment counts at motif-containing peaks for a
given motif.
5.4 Hematopoietic differentiation data processing
We used preexisting RNA- and DNase I-seq data (aligned to genome assembly hg19) of
hematopoietic differentiation (González, Setty, and Leslie 2015) to compare against our
data. We used data from the website provided in the paper
(http://cbio.mskcc.org/public/Leslie/Early_enhancer_establishment/) to download
annotations of peaks (peaksTable.txt), counts of DNase-seq (DNaseCnts.txt), and RNAseq counts (RNAseqCnts.txt). Counts presented in these data files were quantile
normalized and averaged when biological replicates were available. We filtered peaks
with “CD14” or “CD34” under the “accessPattern” annotation to choose for peaks that
were relevant for comparing HSPCs to monocytes. We used a log2 fold change of greater
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than or equal to 2 as a cutoff for assigning differential peaks. We used the preexisting
annotations of genes for each peak for peak-gene mapping. For determining the log2 fold
change in gene expression we discarded genes whose maximum expression value across
the two conditions was fewer than 5 quantile-normalized units.
For visualization of this data set with our own accessibility data, we realigned raw
fastq files DNase-seq files to the hg38 assembly using bowtie v2.3.4.1 and filtered out
low-quality alignments with samtools v1.1 to generate new .bam alignment files. The
alignment files were combined using samtools merge in a single .bam file per cell type.
Bam files were converted to .bigWig format using deeptools 3.5.1 (Ramírez et al, 2016)
“bamCoverage -- normalizeUsing CPM” to create a ‘consensus’ .bigWig for visualization.
Peaks for CD34+ and CD14+ samples were made by filtering peaks annotated for these
populations in the “accessPattern” column and creating separate .bed files using a
custom script. The peak location in these .bed files were then lifted over from hg19 to
hg38 using UCSC hgLiftOver. For comparing the overlap of peaks between data sets, we
created consensus peak sets across all sample types and used the bedtools intersect
function to quantify the proportion of peaks that intersected between the hematopoietic
differentiation and signaling data.
5.5 Peak annotation
Peaks were annotated using ChIPseeker (Yu, Wang, and He 2015) to determine the
relative proportion of features in the data from González et al., 2015 (DNAse-seq) and
Sanford et al., 2020 (ATAC-seq). For ease of visualization, certain categories like the
three promoter categories were collapsed into one. ChiPseeker was also used to identify
the nearest transcriptional start site to a gene used for the nearest integration approach
described below. For making scatter plots of change in accessibility versus change in
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expression annotated by peak feature, a custom script was used to combine annotations
from ChIPseeker into four categories: downstream, gene body, integenic, and promoter.
For each of the top 150 most variable transcription factor motifs we identified
using differential accessibility analysis, we used the R bioconductor motifmatchR
package to annotate both the number of motif matches and a log-likelihood match score
for each peak.
5.6 RNA-seq and ATAC-seq data integration
We employed two methods for assigning peaks to genes. In the ‘nearest’ approach, we
used annotation from ChIPseeker to assign each peak to the nearest transcriptional start
site. With this method, each peak is uniquely mapped to a single gene. In the ‘window’
approach we used a window of 50 kilobases on either side of the transcriptional start site
(100 kilobases in total) to assign peaks to a gene, which could result in a peak being
assigned to multiple genes.
5.7 Track Visualization
We visualized accessibility data using the web based version of integrative genomics
viewer (IGV) (Robinson et al. 2011, 2020). We prepared accessibility data for
visualization by taking consensus files and converting them to .bigWig file format with
either fragments per million or counts per million normalization. Bed files for identifying
peaks were created using custom scripts.
5.8 Statistics and software
Unless otherwise stated, we performed analyses using R v4.1.0 with data manipulation
and visualization done with tidyverse v1.3.1 (Wickham et al. 2019) and ggpubr v0.4.0.
We used a Kolmogorov-Smirnov test to compare means. Unless otherwise stated, 95%
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confidence intervals for Pearson’s r were calculated by bootstrapping using 10,000
replicates.
5.9 Reproducible analyses
All data and remaining code for these analyses can be found at
https://www.dropbox.com/sh/qbjuagz511c072g/AAChvYMjdoG7A0eNdqbEmaUla?dl=
0. Analyses were done in R or on the command line. We used a selection of color-blind
friendly colors from a custom palette.

99

BIBLIOGRAPHY
Achinger-Kawecka, Joanna, Fatima Valdes-Mora, Phuc-Loi Luu, Katherine A. Giles, C.
Elizabeth Caldon, Wenjia Qu, Shalima Nair, et al. 2020. “Epigenetic
Reprogramming at Estrogen-Receptor Binding Sites Alters 3D Chromatin
Landscape in Endocrine-Resistant Breast Cancer.” Nature Communications 11
(1): 1–17.
Ackermann, Amanda M., Zhiping Wang, Jonathan Schug, Ali Naji, and Klaus H.
Kaestner. 2016. “Integration of ATAC-Seq and RNA-Seq Identifies Human Alpha
Cell and Beta Cell Signature Genes.” Molecular Metabolism 5 (3): 233–44.
“Agave Americana (century Plant).” n.d. CABI. Accessed May 26, 2022.
https://www.cabi.org/isc/datasheet/3851.
Alexaki, Vasileia-Ismini, Delphine Javelaud, Leon C. L. Van Kempen, Khalid S.
Mohammad, Sylviane Dennler, Flavie Luciani, Keith S. Hoek, et al. 2010. “GLI2Mediated Melanoma Invasion and Metastasis.” Journal of the National Cancer
Institute.
Almeida, Bernardo P. de, Franziska Reiter, Michaela Pagani, and Alexander Stark. 2022.
“DeepSTARR Predicts Enhancer Activity from DNA Sequence and Enables the de
Novo Design of Synthetic Enhancers.” Nature Genetics 54 (5): 613–24.
Ampuja, M., T. Rantapero, A. Rodriguez-Martinez, M. Palmroth, E. L. Alarmo, M.
Nykter, and A. Kallioniemi. 2017. “Integrated RNA-Seq and DNase-Seq Analyses
Identify Phenotype-Specific BMP4 Signaling in Breast Cancer.” BMC Genomics
18 (1): 68.
Angelini, Claudia, and Valerio Costa. 2014. “Understanding Gene Regulatory
Mechanisms by Integrating ChIP-Seq and RNA-Seq Data: Statistical Solutions to
Biological Problems.” Frontiers in Cell and Developmental Biology 2
(September): 51.
Arozarena, Imanol, and Claudia Wellbrock. 2019. “Phenotype Plasticity as Enabler of
Melanoma Progression and Therapy Resistance.” Nature Reviews. Cancer 19 (7):
377–91.
Åström, Karl Johan, and Richard M. Murray. 2010. Feedback Systems. Princeton
University Press.
Bannister, Andrew J., and Tony Kouzarides. 2011. “Regulation of Chromatin by Histone
Modifications.” Cell Research 21 (3): 381–95.
Barski, Artem, Suresh Cuddapah, Kairong Cui, Tae-Young Roh, Dustin E. Schones,
Zhibin Wang, Gang Wei, Iouri Chepelev, and Keji Zhao. 2007. “High-Resolution
Profiling of Histone Methylations in the Human Genome.” Cell 129 (4): 823–37.
Benton, Christopher B., Warren Fiskus, and Kapil N. Bhalla. 2017. “Targeting Histone
Acetylation: Readers and Writers in Leukemia and Cancer.” Cancer Journal 23
(5): 286–91.
Biddie, Simon C., Sam John, Pete J. Sabo, Robert E. Thurman, Thomas A. Johnson, R.
Louis Schiltz, Tina B. Miranda, et al. 2011. “Transcription Factor AP1 Potentiates
Chromatin Accessibility and Glucocorticoid Receptor Binding.” Molecular Cell 43
(1): 145–55.
Boyle, Alan P., Sean Davis, Hennady P. Shulha, Paul Meltzer, Elliott H. Margulies,
Zhiping Weng, Terrence S. Furey, and Gregory E. Crawford. 2008. “High100

Resolution Mapping and Characterization of Open Chromatin across the
Genome.” Cell 132 (2): 311–22.
Buenrostro, Jason D., Paul G. Giresi, Lisa C. Zaba, Howard Y. Chang, and William J.
Greenleaf. 2013. “Transposition of Native Chromatin for Fast and Sensitive
Epigenomic Profiling of Open Chromatin, DNA-Binding Proteins and
Nucleosome Position.” Nature Methods 10 (12): 1213–18.
Buenrostro, Jason D., Beijing Wu, Ulrike M. Litzenburger, Dave Ruff, Michael L.
Gonzales, Michael P. Snyder, Howard Y. Chang, and William J. Greenleaf. 2015.
“Single-Cell Chromatin Accessibility Reveals Principles of Regulatory Variation.”
Nature 523 (7561): 486–90.
Bunina, Daria, Nade Abazova, Nichole Diaz, Kyung-Min Noh, Jeroen Krijgsveld, and
Judith B. Zaugg. 2020. “Genomic Rewiring of SOX2 Chromatin Interaction
Network during Differentiation of ESCs to Postmitotic Neurons.” Cell Systems 10
(6): 480–94.e8.
Cao, Yi, Zizhen Yao, Deepayan Sarkar, Michael Lawrence, Gilson J. Sanchez, Maura H.
Parker, Kyle L. MacQuarrie, et al. 2010. “Genome-Wide MyoD Binding in
Skeletal Muscle Cells: A Potential for Broad Cellular Reprogramming.”
Developmental Cell 18 (4): 662–74.
Chen, Amy F., Benjamin Parks, Arwa S. Kathiria, Benjamin Ober-Reynolds, Jorg J.
Goronzy, and William J. Greenleaf. 2022. “NEAT-Seq: Simultaneous Profiling of
Intra-Nuclear Proteins, Chromatin Accessibility and Gene Expression in Single
Cells.” Nature Methods 19 (5): 547–53.
Cheng, Chao, Roger Alexander, Renqiang Min, Jing Leng, Kevin Y. Yip, Joel Rozowsky,
Koon-Kiu Yan, et al. 2012. “Understanding Transcriptional Regulation by
Integrative Analysis of Transcription Factor Binding Data.” Genome Research 22
(9): 1658–67.
Cheng, Chao, and Mark Gerstein. 2012. “Modeling the Relative Relationship of
Transcription Factor Binding and Histone Modifications to Gene Expression
Levels in Mouse Embryonic Stem Cells.” Nucleic Acids Research 40 (2): 553–68.
Cheng, Chao, Koon-Kiu Yan, Woochang Hwang, Jiang Qian, Nitin Bhardwaj, Joel
Rozowsky, Zhi John Lu, et al. 2011. “Construction and Analysis of an Integrated
Regulatory Network Derived from High-Throughput Sequencing Data.” PLoS
Computational Biology 7 (11): e1002190.
Cheng, Chao, Koon-Kiu Yan, Kevin Y. Yip, Joel Rozowsky, Roger Alexander, Chong
Shou, and Mark Gerstein. 2011. “A Statistical Framework for Modeling Gene
Expression Using Chromatin Features and Application to modENCODE
Datasets.” Genome Biology 12 (2): R15.
Chen, Xi, Ricardo J. Miragaia, Kedar Nath Natarajan, and Sarah A. Teichmann. 2018. “A
Rapid and Robust Method for Single Cell Chromatin Accessibility Profiling.”
Nature Communications 9 (1): 5345.
Clayton, A. L., T. R. Hebbes, A. W. Thorne, and C. Crane-Robinson. 1993. “Histone
Acetylation and Gene Induction in Human Cells.” FEBS Letters 336 (1): 23–26.
Corces, M. Ryan, Jason D. Buenrostro, Beijing Wu, Peyton G. Greenside, Steven M.
Chan, Julie L. Koenig, Michael P. Snyder, et al. 2016. “Lineage-Specific and
Single-Cell Chromatin Accessibility Charts Human Hematopoiesis and Leukemia
Evolution.” Nature Genetics 48 (10): 1193–1203.
Corces, M. Ryan, Jeffrey M. Granja, Shadi Shams, Bryan H. Louie, Jose A. Seoane,
Wanding Zhou, Tiago C. Silva, et al. 2018. “The Chromatin Accessibility
101

Landscape of Primary Human Cancers.” Science 362 (6413).
https://doi.org/10.1126/science.aav1898.
Corces, M. Ryan, Alexandro E. Trevino, Emily G. Hamilton, Peyton G. Greenside,
Nicholas A. Sinnott-Armstrong, Sam Vesuna, Ansuman T. Satpathy, et al. 2017.
“An Improved ATAC-Seq Protocol Reduces Background and Enables
Interrogation of Frozen Tissues.” Nature Methods 14 (10): 959–62.
Creyghton, Menno P., Albert W. Cheng, G. Grant Welstead, Tristan Kooistra, Bryce W.
Carey, Eveline J. Steine, Jacob Hanna, et al. 2010. “Histone H3K27ac Separates
Active from Poised Enhancers and Predicts Developmental State.” Proceedings of
the National Academy of Sciences of the United States of America 107 (50):
21931–36.
Cusanovich, Darren A., Riza Daza, Andrew Adey, Hannah A. Pliner, Lena Christiansen,
Kevin L. Gunderson, Frank J. Steemers, Cole Trapnell, and Jay Shendure. 2015.
“Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial
Cellular Indexing.” Science 348 (6237): 910–14.
Debreu, G. 1954. “VALUATION EQUILIBRIUM AND PARETO OPTIMUM.”
Proceedings of the National Academy of Sciences of the United States of
America 40 (7): 588–92.
Despang, Alexandra, Robert Schöpflin, Martin Franke, Salaheddine Ali, Ivana Jerković,
Christina Paliou, Wing-Lee Chan, et al. 2019. “Functional Dissection of the Sox9Kcnj2 Locus Identifies Nonessential and Instructive Roles of TAD Architecture.”
Nature Genetics 51 (8): 1263–71.
Dong, Xianjun, Melissa C. Greven, Anshul Kundaje, Sarah Djebali, James B. Brown,
Chao Cheng, Thomas R. Gingeras, et al. 2012. “Modeling Gene Expression Using
Chromatin Features in Various Cellular Contexts.” Genome Biology 13 (9): R53.
Emert, Benjamin L., Christopher J. Cote, Eduardo A. Torre, Ian P. Dardani, Connie L.
Jiang, Naveen Jain, Sydney M. Shaffer, and Arjun Raj. 2021. “Variability within
Rare Cell States Enables Multiple Paths toward Drug Resistance.” Nature
Biotechnology, February. https://doi.org/10.1038/s41587-021-00837-3.
Farmer, Andrew, Sandra Thibivilliers, Kook Hui Ryu, John Schiefelbein, and Marc
Libault. 2021. “Single-Nucleus RNA and ATAC Sequencing Reveals the Impact of
Chromatin Accessibility on Gene Expression in Arabidopsis Roots at the SingleCell Level.” Molecular Plant 14 (3): 372–83.
Feng, Jian, Matthew Wilkinson, Xiaochuan Liu, Immanuel Purushothaman, Deveroux
Ferguson, Vincent Vialou, Ian Maze, et al. 2014. “Chronic Cocaine-Regulated
Epigenomic Changes in Mouse Nucleus Accumbens.” Genome Biology 15 (4):
R65.
Francí, C., M. Takkunen, N. Dave, F. Alameda, S. Gómez, R. Rodríguez, M. Escrivà, et al.
2006. “Expression of Snail Protein in Tumor-Stroma Interface.” Oncogene 25
(37): 5134–44.
Fulco, Charles P., Joseph Nasser, Thouis R. Jones, Glen Munson, Drew T. Bergman,
Vidya Subramanian, Sharon R. Grossman, et al. 2019. “Activity-by-Contact
Model of Enhancer-Promoter Regulation from Thousands of CRISPR
Perturbations.” Nature Genetics 51 (12): 1664–69.
Ghavi-Helm, Yad, Aleksander Jankowski, Sascha Meiers, Rebecca R. Viales, Jan O.
Korbel, and Eileen E. M. Furlong. 2019. “Highly Rearranged Chromosomes
Reveal Uncoupling between Genome Topology and Gene Expression.” Nature
Genetics 51 (8): 1272–82.
102

Gomez-Cabrero, David, Imad Abugessaisa, Dieter Maier, Andrew Teschendorff, Matthias
Merkenschlager, Andreas Gisel, Esteban Ballestar, Erik Bongcam-Rudloff, Ana
Conesa, and Jesper Tegnér. 2014. “Data Integration in the Era of Omics: Current
and Future Challenges.” BMC Systems Biology 8 Suppl 2 (March): I1.
González, Alvaro J., Manu Setty, and Christina S. Leslie. 2015. “Early Enhancer
Establishment and Regulatory Locus Complexity Shape Transcriptional
Programs in Hematopoietic Differentiation.” Nature Genetics 47 (11): 1249–59.
Goyal, Yogesh, Ian P. Dardani, Gianna T. Busch, Benjamin Emert, Dylan Fingerman,
Amanpreet Kaur, Naveen Jain, et al. 2021. “Pre-Determined Diversity in
Resistant Fates Emerges from Homogenous Cells after Anti-Cancer Drug
Treatment.” bioRxiv. https://doi.org/10.1101/2021.12.08.471833.
Gupta, Piyush B., Christine M. Fillmore, Guozhi Jiang, Sagi D. Shapira, Kai Tao,
Charlotte Kuperwasser, and Eric S. Lander. 2011. “Stochastic State Transitions
Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells.” Cell 146 (4):
633–44.
Guss, K. A., C. E. Nelson, A. Hudson, M. E. Kraus, and S. B. Carroll. 2001. “Control of a
Genetic Regulatory Network by a Selector Gene.” Science 292 (5519): 1164–67.
Hart, Yuval, Hila Sheftel, Jean Hausser, Pablo Szekely, Noa Bossel Ben-Moshe, Yael
Korem, Avichai Tendler, Avraham E. Mayo, and Uri Alon. 2015. “Inferring
Biological Tasks Using Pareto Analysis of High-Dimensional Data.” Nature
Methods 12 (3): 233–35, 3 p following 235.
Hesselberth, Jay R., Xiaoyu Chen, Zhihong Zhang, Peter J. Sabo, Richard Sandstrom,
Alex P. Reynolds, Robert E. Thurman, et al. 2009. “Global Mapping of ProteinDNA Interactions in Vivo by Digital Genomic Footprinting.” Nature Methods 6
(4): 283–89.
Hoek, Keith S., Ossia M. Eichhoff, Natalie C. Schlegel, Udo Döbbeling, Nikita Kobert,
Leo Schaerer, Silvio Hemmi, and Reinhard Dummer. 2008. “In Vivo Switching of
Human Melanoma Cells between Proliferative and Invasive States.” Cancer
Research 68 (3): 650–56.
Hoek, Keith S., Natalie C. Schlegel, Patricia Brafford, Antje Sucker, Selma Ugurel, Rajiv
Kumar, Barbara L. Weber, et al. 2006. “Metastatic Potential of Melanomas
Defined by Specific Gene Expression Profiles with No BRAF Signature.” Pigment
Cell Research / Sponsored by the European Society for Pigment Cell Research
and the International Pigment Cell Society 19 (4): 290–302.
Hota, Swetansu K., Kavitha S. Rao, Andrew P. Blair, Ali Khalilimeybodi, Kevin M. Hu,
Reuben Thomas, Kevin So, et al. 2022. “Brahma Safeguards Canalization of
Cardiac Mesoderm Differentiation.” Nature 602 (7895): 129–34.
Hsiung, Chris C-S, Christapher S. Morrissey, Maheshi Udugama, Christopher L. Frank,
Cheryl A. Keller, Songjoon Baek, Belinda Giardine, et al. 2015. “Genome
Accessibility Is Widely Preserved and Locally Modulated during Mitosis.”
Genome Research 25 (2): 213–25.
Jimenez-Sanchez, G., B. Childs, and D. Valle. 2001. “Human Disease Genes.” Nature 409
(6822): 853–55.
Jin, Qihuang, Li-Rong Yu, Lifeng Wang, Zhijing Zhang, Lawryn H. Kasper, Ji-Eun Lee,
Chaochen Wang, Paul K. Brindle, Sharon Y. R. Dent, and Kai Ge. 2011. “Distinct
Roles of GCN5/PCAF-Mediated H3K9ac and CBP/p300-Mediated H3K18/27ac
in Nuclear Receptor Transactivation.” The EMBO Journal 30 (2): 249–62.
103

Jin, Wenfei, Qingsong Tang, Mimi Wan, Kairong Cui, Yi Zhang, Gang Ren, Bing Ni, et al.
2015. “Genome-Wide Detection of DNase I Hypersensitive Sites in Single Cells
and FFPE Tissue Samples.” Nature 528 (7580): 142–46.
John, Sam, Peter J. Sabo, Robert E. Thurman, Myong-Hee Sung, Simon C. Biddie,
Thomas A. Johnson, Gordon L. Hager, and John A. Stamatoyannopoulos. 2011.
“Chromatin Accessibility Pre-Determines Glucocorticoid Receptor Binding
Patterns.” Nature Genetics 43 (3): 264–68.
Josling, Gabrielle A., Shamista A. Selvarajah, Michaela Petter, and Michael F. Duffy.
2012. “The Role of Bromodomain Proteins in Regulating Gene Expression.”
Genes 3 (2): 320–43.
Karabacak Calviello, Aslıhan, Antje Hirsekorn, Ricardo Wurmus, Dilmurat Yusuf, and
Uwe Ohler. 2019. “Reproducible Inference of Transcription Factor Footprints in
ATAC-Seq and DNase-Seq Datasets Using Protocol-Specific Bias Modeling.”
Genome Biology 20 (1): 42.
Kaur, Amanpreet, Brett L. Ecker, Stephen M. Douglass, Curtis H. Kugel 3rd, Marie R.
Webster, Filipe V. Almeida, Rajasekharan Somasundaram, et al. 2019.
“Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma
Metastasis and Affects Immune Cell Motility.” Cancer Discovery 9 (1): 64–81.
Kaur, Amanpreet, Karun Kiani, Dylan Fingerman, Margaret C. Dunagin, Jingxin Li, Ian
Dardani, Eric M. Sanford, et al. 2022. “Metastatic Potential in Clonal Melanoma
Cells Is Driven by a Rare, Early-Invading Subpopulation.” bioRxiv.
https://doi.org/10.1101/2022.04.17.488591.
Kelly, Theresa K., Yaping Liu, Fides D. Lay, Gangning Liang, Benjamin P. Berman, and
Peter A. Jones. 2012. “Genome-Wide Mapping of Nucleosome Positioning and
DNA Methylation within Individual DNA Molecules.” Genome Research 22 (12):
2497–2506.
Kiani, Karun, Eric M. Sanford, Yogesh Goyal, and Arjun Raj. 2022. “Changes in
Chromatin Accessibility Are Not Concordant with Transcriptional Changes for
Single-Factor Perturbations.” bioRxiv.
https://doi.org/10.1101/2022.02.03.478981.
Klein, Hans-Ulrich, Martin Schäfer, Bo T. Porse, Marie S. Hasemann, Katja Ickstadt, and
Martin Dugas. 2014. “Integrative Analysis of Histone ChIP-Seq and Transcription
Data Using Bayesian Mixture Models.” Bioinformatics 30 (8): 1154–62.
Kouzarides, Tony. 2007. “Chromatin Modifications and Their Function.” Cell 128 (4):
693–705.
Lai, Binbin, Weiwu Gao, Kairong Cui, Wanli Xie, Qingsong Tang, Wenfei Jin, Gangqing
Hu, Bing Ni, and Keji Zhao. 2018. “Principles of Nucleosome Organization
Revealed by Single-Cell Micrococcal Nuclease Sequencing.” Nature 562 (7726):
281–85.
Lareau, Caleb A., Fabiana M. Duarte, Jennifer G. Chew, Vinay K. Kartha, Zach D.
Burkett, Andrew S. Kohlway, Dmitry Pokholok, et al. 2019. “Droplet-Based
Combinatorial Indexing for Massive-Scale Single-Cell Chromatin Accessibility.”
Nature Biotechnology 37 (8): 916–24.
Lee, Cheol-Koo, Yoichiro Shibata, Bhargavi Rao, Brian D. Strahl, and Jason D. Lieb.
2004. “Evidence for Nucleosome Depletion at Active Regulatory Regions
Genome-Wide.” Nature Genetics 36 (8): 900–905.

104

Lee, Hsiu-Hsiang, and Manfred Frasch. 2005. “Nuclear Integration of Positive Dpp
Signals, Antagonistic Wg Inputs and Mesodermal Competence Factors during
Drosophila Visceral Mesoderm Induction.” Development 132 (6): 1429–42.
Lettice, Laura A., Simon J. H. Heaney, Lorna A. Purdie, Li Li, Philippe de Beer, Ben A.
Oostra, Debbie Goode, Greg Elgar, Robert E. Hill, and Esther de Graaff. 2003. “A
Long-Range Shh Enhancer Regulates Expression in the Developing Limb and Fin
and Is Associated with Preaxial Polydactyly.” Human Molecular Genetics 12 (14):
1725–35.
Liberzon, Arthur, Chet Birger, Helga Thorvaldsdóttir, Mahmoud Ghandi, Jill P. Mesirov,
and Pablo Tamayo. 2015. “The Molecular Signatures Database (MSigDB)
Hallmark Gene Set Collection.” Cell Systems 1 (6): 417–25.
Liberzon, Arthur, Aravind Subramanian, Reid Pinchback, Helga Thorvaldsdóttir, Pablo
Tamayo, and Jill P. Mesirov. 2011. “Molecular Signatures Database (MSigDB)
3.0.” Bioinformatics 27 (12): 1739–40.
Li, Guoliang, Xiaoan Ruan, Raymond K. Auerbach, Kuljeet Singh Sandhu, Meizhen
Zheng, Ping Wang, Huay Mei Poh, et al. 2012. “Extensive Promoter-Centered
Chromatin Interactions Provide a Topological Basis for Transcription
Regulation.” Cell 148 (1-2): 84–98.
Love, Michael I., Wolfgang Huber, and Simon Anders. 2014. “Moderated Estimation of
Fold Change and Dispersion for RNA-Seq Data with DESeq2.” Genome Biology
15 (12): 550.
Lovrics, Anna, Yu Gao, Bianka Juhász, István Bock, Helen M. Byrne, András Dinnyés,
and Krisztián A. Kovács. 2014. “Boolean Modelling Reveals New Regulatory
Connections between Transcription Factors Orchestrating the Development of
the Ventral Spinal Cord.” PloS One 9 (11): e111430.
Mani, Sendurai A., Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan,
Alicia Y. Zhou, Mary Brooks, et al. 2008. “The Epithelial-Mesenchymal
Transition Generates Cells with Properties of Stem Cells.” Cell 133 (4): 704–15.
Ma, Shaoqian, and Yongyou Zhang. 2020. “Profiling Chromatin Regulatory Landscape:
Insights into the Development of ChIP-Seq and ATAC-Seq.” Molecular
Biomedicine (Online) 1 (1): 9.
Metri, Rahul, Abhilash Mohan, Jérémie Nsengimana, Joanna Pozniak, Carmen MolinaParis, Julia Newton-Bishop, David Bishop, and Nagasuma Chandra. 2017.
“Identification of a Gene Signature for Discriminating Metastatic from Primary
Melanoma Using a Molecular Interaction Network Approach.” Scientific Reports
7 (1): 17314.
Mezger, Anja, Sandy Klemm, Ishminder Mann, Kara Brower, Alain Mir, Magnolia
Bostick, Andrew Farmer, Polly Fordyce, Sten Linnarsson, and William Greenleaf.
2018. “High-Throughput Chromatin Accessibility Profiling at Single-Cell
Resolution.” Nature Communications 9 (1): 3647.
Minnoye, Liesbeth, Georgi K. Marinov, Thomas Krausgruber, Lixia Pan, Alexandre P.
Marand, Stefano Secchia, William J. Greenleaf, et al. 2021. “Chromatin
Accessibility Profiling Methods.” Nature Reviews Methods Primers 1 (1): 1–24.
Mittal, Vivek. 2018. “Epithelial Mesenchymal Transition in Tumor Metastasis.” Annual
Review of Pathology 13 (January): 395–412.
Mold, Jeff E., Martin H. Weissman, Michael Ratz, Michael Hagemann-Jensen, Joanna
Hård, Carl-Johan Eriksson, Hosein Toosi, et al. 2022. “Clonally Heritable Gene
105

Expression Imparts a Layer of Diversity within Cell Types.” bioRxiv.
https://doi.org/10.1101/2022.02.14.480352.
Nair, Venugopalan D., Mital Vasoya, Vishnu Nair, Gregory R. Smith, Hanna Pincas,
Yongchao Ge, Collin M. Douglas, Karyn A. Esser, and Stuart C. Sealfon. 2021.
“Differential Analysis of Chromatin Accessibility and Gene Expression Profiles
Identifies Cis-Regulatory Elements in Rat Adipose and Muscle.” Genomics 113
(6): 3827–41.
Nataraj, Nishanth Belugali, Ilaria Marrocco, and Yosef Yarden. 2021. “Roles for Growth
Factors and Mutations in Metastatic Dissemination.” Biochemical Society
Transactions 49 (3): 1409–23.
Nestorowa, Sonia, Fiona K. Hamey, Blanca Pijuan Sala, Evangelia Diamanti, Mairi
Shepherd, Elisa Laurenti, Nicola K. Wilson, David G. Kent, and Berthold
Göttgens. 2016. “A Single-Cell Resolution Map of Mouse Hematopoietic Stem
and Progenitor Cell Differentiation.” Blood 128 (8): e20–31.
Nguyen, Bastien, Christopher Fong, Anisha Luthra, Shaleigh A. Smith, Renzo G.
DiNatale, Subhiksha Nandakumar, Henry Walch, et al. 2022. “Genomic
Characterization of Metastatic Patterns from Prospective Clinical Sequencing of
25,000 Patients.” Cell 185 (3): 563–75.e11.
Novakovsky, German, Oriol Fornes, Manu Saraswat, Sara Mostafavi, and Wyeth W.
Wasserman. 2022. “ExplaiNN: Interpretable and Transparent Neural Networks
for Genomics.” bioRxiv. https://doi.org/10.1101/2022.05.20.492818.
Olmeda, David, Daniela Cerezo-Wallis, Erica Riveiro-Falkenbach, Paula C. Pennacchi,
Marta Contreras-Alcalde, Nuria Ibarz, Metehan Cifdaloz, et al. 2017. “WholeBody Imaging of Lymphovascular Niches Identifies Pre-Metastatic Roles of
Midkine.” Nature 546 (7660): 676–80.
Ouyang, Zhengqing, Qing Zhou, and Wing Hung Wong. 2009. “ChIP-Seq of
Transcription Factors Predicts Absolute and Differential Gene Expression in
Embryonic Stem Cells.” Proceedings of the National Academy of Sciences of the
United States of America 106 (51): 21521–26.
Paliou, Christina, Philine Guckelberger, Robert Schöpflin, Verena Heinrich, Andrea
Esposito, Andrea M. Chiariello, Simona Bianco, et al. 2019. “Preformed
Chromatin Topology Assists Transcriptional Robustness of Shh during Limb
Development.” Proceedings of the National Academy of Sciences of the United
States of America 116 (25): 12390–99.
Pique-Regi, Roger, Jacob F. Degner, Athma A. Pai, Daniel J. Gaffney, Yoav Gilad, and
Jonathan K. Pritchard. 2011. “Accurate Inference of Transcription Factor Binding
from DNA Sequence and Chromatin Accessibility Data.” Genome Research 21
(3): 447–55.
Pliner, Hannah A., Jonathan S. Packer, José L. McFaline-Figueroa, Darren A.
Cusanovich, Riza M. Daza, Delasa Aghamirzaie, Sanjay Srivatsan, et al. 2018.
“Cicero Predicts Cis-Regulatory DNA Interactions from Single-Cell Chromatin
Accessibility Data.” Molecular Cell 71 (5): 858–71.e8.
Pogo, B. G., V. G. Allfrey, and A. E. Mirsky. 1966. “RNA Synthesis and Histone
Acetylation during the Course of Gene Activation in Lymphocytes.” Proceedings
of the National Academy of Sciences of the United States of America 55 (4):
805–12.

106

Polyak, Kornelia, and Robert A. Weinberg. 2009. “Transitions between Epithelial and
Mesenchymal States: Acquisition of Malignant and Stem Cell Traits.” Nature
Reviews. Cancer 9 (4): 265–73.
Quinn, Jeffrey J., Matthew G. Jones, Ross A. Okimoto, Shigeki Nanjo, Michelle M. Chan,
Nir Yosef, Trever G. Bivona, and Jonathan S. Weissman. 2021. “Single-Cell
Lineages Reveal the Rates, Routes, and Drivers of Metastasis in Cancer
Xenografts.” Science 371 (6532). https://doi.org/10.1126/science.abc1944.
Rada-Iglesias, Alvaro, Ruchi Bajpai, Tomek Swigut, Samantha A. Brugmann, Ryan A.
Flynn, and Joanna Wysocka. 2011. “A Unique Chromatin Signature Uncovers
Early Developmental Enhancers in Humans.” Nature 470 (7333): 279–83.
Raj, Arjun, and Alexander van Oudenaarden. 2008. “Nature, Nurture, or Chance:
Stochastic Gene Expression and Its Consequences.” Cell 135 (2): 216–26.
Ramirez, Ricardo N., Nicole C. El-Ali, Mikayla Anne Mager, Dana Wyman, Ana Conesa,
and Ali Mortazavi. 2017. “Dynamic Gene Regulatory Networks of Human
Myeloid Differentiation.” Cell Systems 4 (4): 416–29.e3.
Raum, Jeffrey C., Kevin Gerrish, Isabella Artner, Eva Henderson, Min Guo, Lori Sussel,
Jonathan C. Schisler, Christopher B. Newgard, and Roland Stein. 2006. “FoxA2,
Nkx2.2, and PDX-1 Regulate Islet Beta-Cell-Specific mafA Expression through
Conserved Sequences Located between Base Pairs -8118 and -7750 Upstream
from the Transcription Start Site.” Molecular and Cellular Biology 26 (15):
5735–43.
Riolo, Rick, Ekaterina Vladislavleva, Marylyn D. Ritchie, and Jason H. Moore. 2013.
Genetic Programming Theory and Practice X. Springer Science & Business
Media.
Robertson, Gordon, Martin Hirst, Matthew Bainbridge, Misha Bilenky, Yongjun Zhao,
Thomas Zeng, Ghia Euskirchen, et al. 2007. “Genome-Wide Profiles of STAT1
DNA Association Using Chromatin Immunoprecipitation and Massively Parallel
Sequencing.” Nature Methods 4 (8): 651–57.
Robinson, James T., Helga Thorvaldsdóttir, Douglass Turner, and Jill P. Mesirov. 2020.
“Igv.js: An Embeddable JavaScript Implementation of the Integrative Genomics
Viewer (IGV).” bioRxiv. https://doi.org/10.1101/2020.05.03.075499.
Robinson, James T., Helga Thorvaldsdóttir, Wendy Winckler, Mitchell Guttman, Eric S.
Lander, Gad Getz, and Jill P. Mesirov. 2011. “Integrative Genomics Viewer.”
Nature Biotechnology 29 (1): 24–26.
Samstein, Robert M., Aaron Arvey, Steven Z. Josefowicz, Xiao Peng, Alex Reynolds,
Richard Sandstrom, Shane Neph, et al. 2012. “Foxp3 Exploits a Pre-Existent
Enhancer Landscape for Regulatory T Cell Lineage Specification.” Cell 151 (1):
153–66.
Sanford, Eric M., Benjamin L. Emert, Allison Coté, and Arjun Raj. 2020. “Gene
Regulation Gravitates toward Either Addition or Multiplication When Combining
the Effects of Two Signals.” eLife 9 (December).
https://doi.org/10.7554/eLife.59388.
Satpathy, Ansuman T., Jeffrey M. Granja, Kathryn E. Yost, Yanyan Qi, Francesca Meschi,
Geoffrey P. McDermott, Brett N. Olsen, et al. 2019. “Massively Parallel SingleCell Chromatin Landscapes of Human Immune Cell Development and
Intratumoral T Cell Exhaustion.” Nature Biotechnology 37 (8): 925–36.

107

Schep, Alicia N., Beijing Wu, Jason D. Buenrostro, and William J. Greenleaf. 2017.
“chromVAR: Inferring Transcription-Factor-Associated Accessibility from SingleCell Epigenomic Data.” Nature Methods 14 (10): 975–78.
Schones, Dustin E., Kairong Cui, Suresh Cuddapah, Tae-Young Roh, Artem Barski,
Zhibin Wang, Gang Wei, and Keji Zhao. 2008. “Dynamic Regulation of
Nucleosome Positioning in the Human Genome.” Cell 132 (5): 887–98.
Shaffer, Sydney M., Margaret C. Dunagin, Stefan R. Torborg, Eduardo A. Torre,
Benjamin Emert, Clemens Krepler, Marilda Beqiri, et al. 2017. “Rare Cell
Variability and Drug-Induced Reprogramming as a Mode of Cancer Drug
Resistance.” Nature 546 (7658): 431–35.
Sharma, Sreenath V., Diana Y. Lee, Bihua Li, Margaret P. Quinlan, Fumiyuki Takahashi,
Shyamala Maheswaran, Ultan McDermott, et al. 2010. “A Chromatin-Mediated
Reversible Drug-Tolerant State in Cancer Cell Subpopulations.” Cell 141 (1): 69–
80.
Slattery, Matthew, Todd Riley, Peng Liu, Namiko Abe, Pilar Gomez-Alcala, Iris Dror,
Tianyin Zhou, et al. 2011. “Cofactor Binding Evokes Latent Differences in DNA
Binding Specificity between Hox Proteins.” Cell 147 (6): 1270–82.
Smith, Richard, Leah A. Owen, Deborah J. Trem, Jenny S. Wong, Jennifer S. Whangbo,
Todd R. Golub, and Stephen L. Lessnick. 2006. “Expression Profiling of
EWS/FLI Identifies NKX2.2 as a Critical Target Gene in Ewing’s Sarcoma.”
Cancer Cell 9 (5): 405–16.
Song, Xue, Zhongyun Zhao, Beth Barber, Amanda M. Farr, Boris Ivanov, and Marilyn
Novich. 2015. “Overall Survival in Patients with Metastatic Melanoma.” Current
Medical Research and Opinion 31 (5): 987–91.
Spitz, François, and Eileen E. M. Furlong. 2012. “Transcription Factors: From Enhancer
Binding to Developmental Control.” Nature Reviews. Genetics 13 (9): 613–26.
Starks, Rebekah R., Anilisa Biswas, Ashish Jain, and Geetu Tuteja. 2019. “Combined
Analysis of Dissimilar Promoter Accessibility and Gene Expression Profiles
Identifies Tissue-Specific Genes and Actively Repressed Networks.” Epigenetics
& Chromatin 12 (1): 16.
Strahl, B. D., and C. D. Allis. 2000. “The Language of Covalent Histone Modifications.”
Nature 403 (6765): 41–45.
Strogatz, Steven, Mark Friedman, A. John Mallinckrodt, and Susan McKay. 1994.
“Nonlinear Dynamics and Chaos: With Applications to Physics, Biology,
Chemistry, and Engineering.” Computer Physics Communications 8 (5): 532.
Sung, Myong-Hee, Songjoon Baek, and Gordon L. Hager. 2016. “Genome-Wide
Footprinting: Ready for Prime Time?” Nature Methods 13 (3): 222–28.
Symmons, Orsolya, and Arjun Raj. 2016. “What’s Luck Got to Do with It: Single Cells,
Multiple Fates, and Biological Nondeterminism.” Molecular Cell 62 (5): 788–
802.
Taniguchi, Yasushi. 2016. “The Bromodomain and Extra-Terminal Domain (BET)
Family: Functional Anatomy of BET Paralogous Proteins.” International Journal
of Molecular Sciences 17 (11). https://doi.org/10.3390/ijms17111849.
Tena, Juan J., and José M. Santos-Pereira. 2021. “Topologically Associating Domains
and Regulatory Landscapes in Development, Evolution and Disease.” Frontiers
in Cell and Developmental Biology 9 (July): 702787.

108

Teves, Sheila S., Luye An, Anders S. Hansen, Liangqi Xie, Xavier Darzacq, and Robert
Tjian. 2016. “A Dynamic Mode of Mitotic Bookmarking by Transcription
Factors.” eLife 5 (November). https://doi.org/10.7554/eLife.22280.
Thurman, Robert E., Eric Rynes, Richard Humbert, Jeff Vierstra, Matthew T. Maurano,
Eric Haugen, Nathan C. Sheffield, et al. 2012. “The Accessible Chromatin
Landscape of the Human Genome.” Nature 489 (7414): 75–82.
Torre, Eduardo A., Eri Arai, Sareh Bayatpour, Connie L. Jiang, Lauren E. Beck,
Benjamin L. Emert, Sydney M. Shaffer, et al. 2021. “Genetic Screening for SingleCell Variability Modulators Driving Therapy Resistance.” Nature Genetics 53 (1):
76–85.
Torre-Ubieta, Luis de la, Jason L. Stein, Hyejung Won, Carli K. Opland, Dan Liang,
Daning Lu, and Daniel H. Geschwind. 2018. “The Dynamic Landscape of Open
Chromatin during Human Cortical Neurogenesis.” Cell 172 (1-2): 289–304.e18.
Turner, Noel, Olivia Ware, and Marcus Bosenberg. 2018. “Genetics of Metastasis:
Melanoma and Other Cancers.” Clinical & Experimental Metastasis 35 (5-6):
379–91.
Vaishnav, Eeshit Dhaval, Carl G. de Boer, Jennifer Molinet, Moran Yassour, Lin Fan,
Xian Adiconis, Dawn A. Thompson, Joshua Z. Levin, Francisco A. Cubillos, and
Aviv Regev. 2022. “The Evolution, Evolvability and Engineering of Gene
Regulatory DNA.” Nature 603 (7901): 455–63.
Voss, Ty C., R. Louis Schiltz, Myong-Hee Sung, Paul M. Yen, John A.
Stamatoyannopoulos, Simon C. Biddie, Thomas A. Johnson, Tina B. Miranda,
Sam John, and Gordon L. Hager. 2011. “Dynamic Exchange at Regulatory
Elements during Chromatin Remodeling Underlies Assisted Loading
Mechanism.” Cell 146 (4): 544–54.
Weintraub, H., and M. Groudine. 1976. “Chromosomal Subunits in Active Genes Have an
Altered Conformation.” Science 193 (4256): 848–56.
West, Jason A., April Cook, Burak H. Alver, Matthias Stadtfeld, Aimee M. Deaton,
Konrad Hochedlinger, Peter J. Park, Michael Y. Tolstorukov, and Robert E.
Kingston. 2014. “Nucleosomal Occupancy Changes Locally over Key Regulatory
Regions during Cell Differentiation and Reprogramming.” Nature
Communications 5 (August): 4719.
Wickham, Hadley, Mara Averick, Jennifer Bryan, Winston Chang, Lucy McGowan,
Romain François, Garrett Grolemund, et al. 2019. “Welcome to the Tidyverse.”
Journal of Open Source Software 4 (43): 1686.
Williamson, Iain, Lauren Kane, Paul S. Devenney, Ilya M. Flyamer, Eve Anderson, Fiona
Kilanowski, Robert E. Hill, Wendy A. Bickmore, and Laura A. Lettice. 2019.
“Developmentally Regulated Shh Expression Is Robust to TAD Perturbations.”
Development 146 (19). https://doi.org/10.1242/dev.179523.
Wu, C., Y. C. Wong, and S. C. Elgin. 1979. “The Chromatin Structure of Specific Genes:
II. Disruption of Chromatin Structure during Gene Activity.” Cell 16 (4): 807–14.
Wu, Tianzhi, Erqiang Hu, Shuangbin Xu, Meijun Chen, Pingfan Guo, Zehan Dai, Tingze
Feng, et al. 2021. “clusterProfiler 4.0: A Universal Enrichment Tool for
Interpreting Omics Data.” Innovation (New York, N.Y.) 2 (3): 100141.
Xu, X., Z. Yin, J. B. Hudson, E. L. Ferguson, and M. Frasch. 1998. “Smad Proteins Act in
Combination with Synergistic and Antagonistic Regulators to Target Dpp
Responses to the Drosophila Mesoderm.” Genes & Development 12 (15): 2354–
70.
109

Yang, Yajie, Justin Fear, Jianhong Hu, Irina Haecker, Lei Zhou, Rolf Renne, David
Bloom, and Lauren M. McIntyre. 2014. “Leveraging Biological Replicates to
Improve Analysis in ChIP-Seq Experiments.” Computational and Structural
Biotechnology Journal 9 (January): e201401002.
Yoshida, Akihiko, Shigeki Sekine, Koji Tsuta, Masashi Fukayama, Koh Furuta, and
Hitoshi Tsuda. 2012. “NKX2.2 Is a Useful Immunohistochemical Marker for
Ewing Sarcoma.” The American Journal of Surgical Pathology 36 (7): 993–99.
Yu, Guangchuang, Li-Gen Wang, and Qing-Yu He. 2015. “ChIPseeker: An
R/Bioconductor Package for ChIP Peak Annotation, Comparison and
Visualization.” Bioinformatics 31 (14): 2382–83.
Zaidi, Sayyed K., Daniel W. Young, Martin A. Montecino, Jane B. Lian, Andre J. van
Wijnen, Janet L. Stein, and Gary S. Stein. 2010. “Mitotic Bookmarking of Genes:
A Novel Dimension to Epigenetic Control.” Nature Reviews. Genetics 11 (8):
583–89.
Zaret, Kenneth S. 2020. “Pioneer Transcription Factors Initiating Gene Network
Changes.” Annual Review of Genetics 54 (November): 367–85.
Zhang, Yanjun, Zhongxing Sun, Junqi Jia, Tianjiao Du, Nachuan Zhang, Yin Tang, Yuan
Fang, and Dong Fang. 2021. “Overview of Histone Modification.” In Histone
Mutations and Cancer, edited by Dong Fang and Junhong Han, 1–16. Singapore:
Springer Singapore.
Zhang, Yong, Tao Liu, Clifford A. Meyer, Jérôme Eeckhoute, David S. Johnson, Bradley
E. Bernstein, Chad Nusbaum, et al. 2008. “Model-Based Analysis of ChIP-Seq
(MACS).” Genome Biology 9 (9): R137.
Zhou, Yeqiao, Jelena Petrovic, Jingru Zhao, Wu Zhang, Ashkan Bigdeli, Zhen Zhang,
Shelley L. Berger, Warren S. Pear, and Robert B. Faryabi. 2022. “EBF1 Nuclear
Repositioning Instructs Chromatin Refolding to Promote Therapy Resistance in T
Leukemic Cells.” Molecular Cell 82 (5): 1003–20.e15.

110

